Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036782	pf-gluk	mmol/l (mmol/l)	3141	4110	0.17%
3036782	pf-gluk	— (—)	367	393	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dyspnoea

1077

2155

3.75

309.43

1.4

1.3

6.41

6.24

mmol/l

0.92

1014

1972

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1169

1302

5.53

307.65

1.4

1.3

6.37

6.15

mmol/l

1.17

1073

1220

Influenza and pneumonia

1281

1565

5.28

307.65

1.4

1.3

6.36

6.17

mmol/l

1.11

1172

1461

Any death

1006

1247

5.94

307.65

1.4

1.3

6.36

6.39

mmol/l

0.11

945

1139

Pneumonias (Asthma/COPD co-morbidities)

1310

1599

5.59

307.65

1.4

1.3

6.40

6.18

mmol/l

1.31

1201

1488

Pleural effusion

1515

300

64.54

307.65

1.5

1.2

5.90

7.13

mmol/l

6.77

1429

270

Pyothorax

353

157

28.28

307.65

1.6

1.4

4.33

6.49

mmol/l

13.34

293

152

Heart failure,strict

911

1004

6.59

307.65

1.4

1.3

7.18

5.51

mmol/l

36.49

862

915

Other pleural conditions

857

190

55.80

307.65

1.6

1.2

5.91

7.26

mmol/l

4.69

799

177

Other medical care

815

1358

5.55

307.65

1.4

1.3

6.10

6.29

mmol/l

0.84

774

1241

Asthma, unspecified (mode), excluding more controls

383

195

14.86

307.65

1.4

1.1

6.36

6.50

mmol/l

0.25

348

173

ILD differential diagnosis

649

347

9.47

307.65

1.4

1.1

6.24

6.82

mmol/l

2.81

600

316

Malignant neoplasm of bronchus and lung, including Hilmo

501

563

7.78

307.65

1.3

1.4

5.95

6.74

mmol/l

4.56

475

512

All pneumoniae

1309

1597

5.57

307.65

1.3

6.38

6.18

mmol/l

1.09

1201

1485

Other pulmonary diagnosis

658

347

9.60

307.65

1.4

1.1

6.26

6.82

mmol/l

2.70

608

316

1169

1302

5.53

307.65

1.4

1.3

6.37

6.15

mmol/l

1.17

1073

1220

Suppurative and necrotic conditions of lower respiratory tract

387

194

23.99

307.65

1.5

1.4

4.50

6.52

mmol/l

12.66

327

184

Heart failure, not strict

1028

1291

5.52

307.65

1.4

1.3

7.05

5.59

mmol/l

31.87

964

1175

All-cause Heart Failure

975

1340

5.28

307.65

1.4

1.3

7.21

5.73

mmol/l

31.07

923

1223

COPD (mode)

376

211

14.31

307.65

1.3

1.1

6.38

7.01

mmol/l

2.16

347

184

Malignant neoplasm of respiratory system and intrathoracic organs

568

553

9.00

307.65

1.4

5.64

6.75

mmol/l

8.79

538

502

COPD differential diagnosis

649

347

9.47

307.65

1.4

1.1

6.24

6.82

mmol/l

2.81

600

316

Excluding asthma or asthma-COPD overlap

651

347

9.50

307.65

1.4

1.1

6.26

6.82

mmol/l

2.68

602

316

Pneumonia, organism unspecified

1240

1517

5.83

307.65

1.3

6.42

6.19

mmol/l

1.28

1140

1415

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1306

1613

5.62

307.65

1.3

6.42

6.19

mmol/l

1.37

1198

1501

Lung cancer and mesothelioma

591

144

37.42

307.65

1.4

1.1

5.69

7.13

mmol/l

6.74

563

125

Other diseases of pleura

2008

795

24.17

307.65

1.5

1.2

6.04

6.93

mmol/l

10.16

1883

716

Heart failure, strict

999

1364

5.31

307.65

1.4

1.3

7.19

5.73

mmol/l

31.09

945

1244

Bacterial infection, other or unspecified

822

1601

4.43

306.70

1.4

1.3

6.30

6.26

mmol/l

0.13

761

1484

Asthma, excluding more controls

456

209

11.47

295.96

1.4

1.1

6.30

6.45

mmol/l

0.34

413

187

Other bacterial diseases

1068

1950

3.73

295.70

1.4

1.3

6.50

6.19

mmol/l

2.15

986

1807

Non-small cell lung cancer, including Hilmo

390

448

8.62

290.20

1.3

1.4

5.82

6.72

mmol/l

4.56

367

406

Asthma, unspecified (mode)

401

327

9.33

288.61

1.4

1.1

6.39

6.88

mmol/l

1.77

365

296

Bacterial infection, other or unspecified

776

1574

4.37

286.85

1.4

1.3

6.34

6.25

mmol/l

0.32

717

1462

Malignant neoplasm of bronchus and lung

434

491

7.67

277.71

1.3

1.4

5.93

6.75

mmol/l

4.21

413

447

Asthma (only as main-diagnosis), excluding more controls

404

209

11.14

274.70

1.4

1.1

6.32

6.45

mmol/l

0.25

368

187

Other bacterial diseases

1039

1878

3.55

263.46

1.4

1.3

6.35

6.20

mmol/l

0.73

959

1739

Later onset COPD, excluding more controls

280

161

13.80

257.26

1.4

1.1

6.30

7.09

mmol/l

2.83

257

138

Heart failure and antihypertensive medication

415

347

8.04

246.84

1.5

1.3

7.29

5.38

mmol/l

19.74

396

313

Oxycodone

609

1227

4.60

242.81

1.4

1.3

5.97

6.39

mmol/l

2.51

570

1131

Renal tubulo-interstitial diseases

953

2113

3.40

238.93

1.4

1.3

7.06

5.98

mmol/l

17.04

888

1946

Asthma

480

345

7.35

238.21

1.4

1.1

6.35

6.82

mmol/l

2.01

436

314

Bacterial pneumoniae

540

973

4.99

236.07

1.4

1.3

6.58

6.22

mmol/l

1.52

488

908

Renal failure

729

1692

3.90

232.65

1.4

1.3

7.34

6.05

mmol/l

17.54

679

1561

Non-small cell lung cancer

283

314

9.46

231.30

1.3

1.4

5.87

6.81

mmol/l

3.35

268

284

Bacterial pneumonia, not elsewhere classified

523

935

5.02

230.38

1.4

1.3

6.60

6.20

mmol/l

1.70

473

871

Diseases of the respiratory system

481

335

7.26

230.30

1.4

1.1

6.30

6.80

mmol/l

1.96

449

309

Non-ischemic cardiomyopathy

495

757

5.41

227.44

1.4

1.3

6.74

5.63

mmol/l

11.30

474

696

Bacterial Sepsis

680

1472

4.03

225.34

1.4

1.3

7.02

6.05

mmol/l

10.67

625

1364

Persons encountering health services for specific procedures and health care

1013

1881

3.26

222.38

1.4

1.3

6.33

6.20

mmol/l

0.66

942

1714

Asthma (only as main-diagnosis)

427

345

7.22

221.11

1.4

1.1

6.33

6.82

mmol/l

2.02

390

314

Non-small cell lung cancer, adenocarcinoma

201

159

13.69

209.84

1.3

5.68

7.06

mmol/l

3.37

188

142

All chronic kidney diseases

707

1587

3.71

206.37

1.4

1.3

7.24

5.95

mmol/l

16.97

662

1459

Septicaemia

587

1376

4.07

202.92

1.4

1.3

6.85

6.21

mmol/l

4.19

534

1281

Asthma (mode)

432

347

6.71

202.62

1.4

1.1

6.30

6.82

mmol/l

2.23

396

316

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

987

2272

3.03

201.15

1.4

1.3

6.67

6.14

mmol/l

5.39

926

2081

Implicit bacterial Sepsis

603

1371

3.98

198.80

1.4

1.3

7.16

6.05

mmol/l

12.36

558

1273

Heart failure and bmi 25plus

490

663

5.11

197.94

1.4

1.3

7.18

5.89

mmol/l

13.93

461

591

Heart failure and coronary heart disease

677

1282

3.83

196.47

1.5

1.4

7.31

6.05

mmol/l

17.28

637

1182

Explicit Sepsis

597

1448

3.92

196.25

1.4

1.3

6.83

6.02

mmol/l

6.58

544

1345

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

789

2191

3.27

195.74

1.4

1.3

6.16

6.41

mmol/l

1.46

734

2024

Abnormal findings on diagnostic imaging of lung

678

1859

3.57

195.17

1.4

1.3

6.08

6.40

mmol/l

1.97

631

1718

Implicit bacterial Sepsis

628

1448

3.82

194.18

1.4

1.3

7.12

6.03

mmol/l

12.69

581

1344

Abnormalities of breathing

836

1439

3.41

194.08

1.4

1.3

6.27

6.10

mmol/l

0.79

768

1319

Implicit Sepsis

812

1893

3.28

193.00

1.4

1.3

7.10

6.02

mmol/l

16.12

751

1748

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

305

461

6.84

192.42

1.3

1.4

5.96

6.74

mmol/l

3.17

284

416

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

127

31.46

188.13

1.6

1.3

4.57

6.82

mmol/l

5.03

120

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

354

643

5.59

181.88

1.3

1.4

5.98

6.70

mmol/l

3.88

331

587

Other septicaemia

522

1289

3.97

176.06

1.4

1.3

6.94

6.21

mmol/l

4.78

476

1199

All kidney diseases

908

2137

2.93

174.89

1.4

1.3

6.91

5.95

mmol/l

13.51

846

1966

Chronic kidney disease

500

1271

3.96

167.80

1.5

1.3

7.45

6.00

mmol/l

14.92

465

1167

COPD/asthma/ILD related infections

829

1302

3.21

167.17

1.4

1.3

6.36

6.15

mmol/l

1.00

760

1220

COPD/asthma related infections

829

1302

3.21

167.17

1.4

1.3

6.36

6.15

mmol/l

1.00

760

1220

Other heart diseases, wide

699

1264

3.41

165.76

1.4

1.3

6.68

5.63

mmol/l

15.12

657

1143

Implicit Sepsis

796

1949

3.02

164.18

1.4

1.3

7.10

5.99

mmol/l

16.84

736

1802

Dialysis, with operation codes

256

387

6.90

161.93

1.5

1.3

7.38

5.83

mmol/l

9.17

240

353

Other heart diseases

369

451

5.40

156.99

1.4

1.2

6.69

5.43

mmol/l

10.53

343

404

Liquid cancers, helper endpoint

427

889

4.26

154.08

1.4

6.35

6.63

mmol/l

1.02

399

813

Malignant neoplasm of mesothelium and soft tissue

134

16.04

152.78

1.6

1.3

4.70

7.13

mmol/l

4.89

129

Early onset COPD, excluding more controls

161

147

11.11

151.57

1.3

1.1

6.57

6.85

mmol/l

0.38

151

132

Non-small cell lung cancer, adenocarcinoma, helper endpoint

201

254

8.54

150.29

1.3

1.4

5.68

6.47

mmol/l

2.27

188

238

Acute renal failure

365

816

4.60

150.22

1.4

1.3

7.38

6.03

mmol/l

11.96

343

739

Non-rheumatic valve diseases

470

849

4.05

149.37

1.4

1.3

6.73

5.60

mmol/l

12.23

442

764

Valvular heart disease excluding rheumatic fever

471

853

4.04

149.36

1.4

1.3

6.72

5.60

mmol/l

12.11

442

765

Bacterial pneumonia (organism specified)

572

1574

3.35

147.98

1.4

1.3

6.61

6.25

mmol/l

1.62

518

1459

Anaemias

190

103

12.19

147.78

1.4

1.2

7.07

5.12

mmol/l

9.24

180

Atrial fibrillation and flutter

301

315

6.28

147.14

1.5

1.3

6.69

5.34

mmol/l

10.03

284

277

Nephropathy related operations

247

408

6.31

143.38

1.5

1.3

7.42

6.18

mmol/l

5.17

231

376

Malignant neoplasm

691

1311

3.15

143.26

1.4

1.3

5.85

6.62

mmol/l

8.62

645

1196

Pneumothorax

136

109

13.03

140.04

1.6

1.2

5.21

7.49

mmol/l

4.67

124

103

Malignant neoplasm, wide definition for exclusion

689

1329

3.07

136.70

1.4

1.3

5.88

6.63

mmol/l

7.87

641

1212

Fever of other and unknown origin

562

1595

3.17

133.20

1.4

1.3

6.18

6.22

mmol/l

0.09

519

1470

First line medication for Crohn's disease

912

1908

2.60

131.92

1.4

1.3

6.09

6.36

mmol/l

1.84

838

1761

Condition for Implicit Sepsis (Organ dysfunction codes)

753

1950

2.75

130.76

1.4

1.3

7.12

5.97

mmol/l

16.90

696

1804

Solid cancers, helper endpoint

660

1296

3.03

128.96

1.4

1.3

5.84

6.62

mmol/l

8.48

615

1182

Atrial fibrillation and flutter with reimbursement

259

263

6.36

126.78

1.4

1.3

6.67

5.39

mmol/l

7.26

242

229

Diseases of arteries, arterioles and capillaries (FINNGEN)

239

259

6.49

123.96

1.4

1.3

6.98

5.43

mmol/l

8.87

221

225

Other diseases of pericardium

117

13.53

122.25

1.6

1.2

6.73

5.91

mmol/l

0.86

107

Any event in cancer register

695

1459

2.83

120.47

1.4

1.3

5.88

6.55

mmol/l

6.97

647

1337

Cardiomyopathy

224

405

5.66

117.81

1.3

6.72

5.47

mmol/l

5.54

211

365

Condition for Implicit Sepsis (Organ dysfunction codes)

732

1926

2.64

117.16

1.4

1.3

6.98

5.96

mmol/l

13.52

675

1779

Erysipelas

616

1766

2.69

104.71

1.4

1.3

6.59

6.22

mmol/l

2.21

569

1634

Non-invasive ventilation

217

372

5.28

102.42

1.4

1.3

6.80

5.17

mmol/l

13.08

194

338

Ascites

161

243

6.93

102.25

1.4

6.20

6.27

mmol/l

0.09

149

222

GASTRO-related operations

520

838

3.13

101.33

1.4

1.3

6.29

6.20

mmol/l

0.25

488

771

Any gastric operation

520

838

3.13

101.33

1.4

1.3

6.29

6.20

mmol/l

0.25

488

771

Care involving dialysis

146

204

7.44

99.39

1.5

1.3

7.68

6.42

mmol/l

2.83

135

187

Oral corticosteroids

870

2271

2.29

99.12

1.4

1.3

6.26

6.28

mmol/l

0.06

799

2101

Non-allergic asthma (mode), excluding more controls

12.39

98.83

1.4

1.1

6.42

6.83

mmol/l

0.51

Respiratory insufficiency

13.81

98.72

1.6

1.1

6.85

7.03

mmol/l

0.16

Other disorders of fluid, electrolyte and acid-base balance

376

1092

3.33

98.05

1.3

6.82

6.18

mmol/l

3.66

350

1001

Aplastic and other anaemias

536

1856

2.73

98.02

1.4

6.83

6.25

mmol/l

3.71

502

1709

Cardiac arrhythmias

388

746

3.40

94.22

1.4

1.3

6.54

5.22

mmol/l

18.19

367

677

ILD medications: prednisolone, methylprednisolone, prednisone

849

2130

2.24

91.05

1.4

1.3

6.26

6.25

mmol/l

0.03

779

1971

Other anaemias

500

1778

2.71

90.67

1.4

6.85

6.25

mmol/l

3.57

469

1634

Other and unspecified anaemias

495

1764

2.71

89.90

1.4

6.89

6.25

mmol/l

3.88

464

1622

Haemorrhage from respiratory passages

366

1036

3.23

89.68

1.3

6.47

6.14

mmol/l

1.32

348

950

Covid-19 confirmed case

409

1393

2.98

89.45

1.4

6.60

6.29

mmol/l

1.16

391

1271

Continuous positive airway pressure

189

303

5.33

88.24

1.3

7.05

5.11

mmol/l

8.78

170

272

Codes for special purposes

491

1859

2.66

87.39

1.4

1.3

6.56

6.24

mmol/l

1.41

466

1701

Provisional assignment of new diseases of uncertain etiology

490

1856

2.66

87.14

1.4

1.3

6.55

6.25

mmol/l

1.35

465

1698

Cardiomyopathy (excluding other)

161

291

5.66

84.88

1.3

6.87

5.52

mmol/l

4.31

151

258

Inflammatory bowel disease treatment related agents

873

2283

2.15

84.80

1.4

1.3

6.22

6.28

mmol/l

0.20

806

2112

Malaise and fatigue

478

1425

2.73

84.79

1.3

1.4

6.52

6.25

mmol/l

1.05

442

1315

ILD medications

852

2138

2.17

84.09

1.4

1.3

6.26

6.25

mmol/l

0.05

780

1978

Diseases of arteries, arterioles and capillaries

657

2085

2.35

83.95

1.3

1.4

7.05

6.17

mmol/l

9.81

601

1932

Erysipelas

489

1668

2.62

82.01

1.4

1.3

6.72

6.22

mmol/l

2.75

454

1545

Pulmonary heart disease, diseases of pulmonary circulation

383

1326

2.94

81.44

1.3

1.4

6.04

6.34

mmol/l

1.24

355

1213

Cardiomyopathies, Primary/intrinsic

152

279

5.57

78.83

1.3

6.91

5.51

mmol/l

4.42

142

248

Implicit viral Sepsis

305

949

3.26

77.96

1.4

1.3

7.21

6.00

mmol/l

7.67

283

873

Metabolic disorders

725

2019

2.21

76.57

1.4

1.3

6.68

6.09

mmol/l

5.24

669

1857

Transplanted organ and tissue status

139

244

5.86

75.72

1.5

1.4

7.27

6.11

mmol/l

2.98

134

224

Pulmonary embolism

344

1179

2.96

74.56

1.3

1.4

5.92

6.38

mmol/l

2.17

318

1075

Cerebrovascular diseases (FINNGEN)

207

333

4.44

73.86

1.4

1.3

6.71

5.40

mmol/l

7.00

200

295

Pulmonary heart disease

344

1187

2.94

73.67

1.3

1.4

5.92

6.38

mmol/l

2.15

318

1083

COPD

489

1618

2.50

73.16

1.3

1.4

6.40

6.29

mmol/l

0.32

449

1494

Hypertensive heart and/or renal disease

305

707

3.27

72.39

1.4

1.3

7.15

5.61

mmol/l

13.03

285

658

Undetermined asthma, excluding more controls

13.46

72.36

1.4

1.1

5.88

6.69

mmol/l

0.98

Asthma-related pneumonia

391

1454

2.72

72.33

1.3

6.44

6.31

mmol/l

0.36

352

1339

Asthma-related pneumonia or sepsis

391

1454

2.72

72.33

1.3

6.44

6.31

mmol/l

0.36

352

1339

Asthma, hospital admissions 3, pneumonia

391

1454

2.72

72.33

1.3

6.44

6.31

mmol/l

0.36

352

1339

L04AD Calcineurin inhibitors

138

254

5.57

71.44

1.5

1.4

7.08

6.09

mmol/l

2.20

132

232

Conduction disorders

259

604

3.52

70.75

1.5

1.3

6.81

5.55

mmol/l

8.38

248

549

Other arrhythmias

400

1110

2.74

70.69

1.4

1.3

6.43

5.67

mmol/l

6.68

380

1001

Certain infectious and parasitic diseases

658

1458

2.27

70.63

1.4

1.3

6.37

6.14

mmol/l

1.13

610

1356

DVT of lower extremities and pulmonary embolism

435

1732

2.53

69.68

1.3

1.4

5.98

6.37

mmol/l

1.97

402

1598

Acute tubulo-interstitial nephritis

498

1817

2.38

68.34

1.4

1.3

6.79

6.00

mmol/l

6.78

463

1685

Cardiovascular diseases (excluding rheumatic etc)

297

510

3.36

68.28

1.4

1.2

6.17

5.41

mmol/l

4.52

272

458

Other chronic obstructive pulmonary disease

467

1579

2.47

68.06

1.3

1.4

6.45

6.28

mmol/l

0.57

431

1460

AV-block

194

418

4.13

67.83

1.5

1.3

6.99

5.45

mmol/l

8.45

187

373

Complications of surgical and medical care, not elsewhere classified

758

2572

2.03

66.84

1.4

1.3

6.52

6.24

mmol/l

1.84

710

2368

ILD, hospital admission 2, with pulmonary infections

134

256

5.37

66.64

1.4

1.3

6.77

6.15

mmol/l

1.18

123

239

Venous thromboembolism

515

2186

2.30

66.34

1.3

1.4

6.06

6.40

mmol/l

1.76

478

2019

Non-allergic asthma (mode)

136

7.20

65.87

1.4

1.1

6.42

6.92

mmol/l

0.88

120

ILD, hospital admissions 3, with pneumonia sepsis

127

237

5.52

64.91

1.5

1.3

6.68

6.26

mmol/l

0.64

118

223

All influenza

207

570

3.67

64.06

1.4

1.3

6.88

6.19

mmol/l

2.25

188

528

Opioids

651

1561

2.18

64.05

1.4

1.3

6.27

6.29

mmol/l

0.08

602

1439

Other chronic obstructive pulmonary disease, including avohilmo

529

1947

2.27

64.03

1.3

1.4

6.42

6.31

mmol/l

0.34

489

1796

Valvular operations

153

339

4.60

63.77

1.5

1.3

6.65

5.36

mmol/l

5.53

146

302

Extracorporeal dialysis

116

205

5.90

63.08

1.5

1.4

7.40

6.40

mmol/l

2.45

108

191

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

691

2199

2.06

62.49

1.4

1.3

6.68

6.08

mmol/l

5.99

643

2015

Bleeding

668

2315

2.07

62.27

1.4

1.3

6.70

6.24

mmol/l

3.44

622

2126

Implicit viral Sepsis

217

631

3.49

62.02

1.4

1.3

7.37

6.01

mmol/l

6.62

205

578

Viral Sepsis

217

631

3.49

62.02

1.4

1.3

7.37

6.01

mmol/l

6.62

205

578

Tramadol

552

1513

2.25

61.79

1.4

1.3

6.43

6.33

mmol/l

0.30

510

1395

COPD, hospital admissions

473

1733

2.33

61.41

1.3

1.4

6.44

6.31

mmol/l

0.38

438

1601

COPD, hospital admissions 3, with asthma pneumonia sepsis

349

1124

2.70

61.22

1.3

1.4

6.59

6.33

mmol/l

0.79

319

1031

Any reimbursement code in KELA

266

384

3.49

61.13

1.4

1.2

6.45

5.42

mmol/l

6.15

244

352

Hypertensive diseases (excluding secondary)

263

456

3.37

60.84

1.4

1.2

6.60

5.43

mmol/l

7.03

236

409

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

158

374

4.30

60.58

1.4

6.23

6.84

mmol/l

1.80

145

337

General symptoms and signs

722

1776

2.05

60.25

1.3

6.40

6.20

mmol/l

0.98

666

1641

COPD, early/later onset

474

1751

2.31

59.93

1.3

1.4

6.44

6.31

mmol/l

0.42

438

1617

Peripheral artery disease

470

1629

2.32

59.64

1.4

7.47

6.14

mmol/l

13.76

428

1511

COPD, hospital admission 2, with asthma infections

376

1278

2.56

59.59

1.3

1.4

6.62

6.32

mmol/l

1.01

345

1176

Paroxysmal tachycardia

150

277

4.57

59.11

1.4

1.3

6.73

5.45

mmol/l

4.98

141

244

Viral pneumonia

131

272

4.90

59.11

1.5

1.3

6.91

6.23

mmol/l

1.51

126

254

Symptoms and signs involving the circulatory and respiratory systems

618

1441

2.16

59.03

1.4

1.3

6.38

6.10

mmol/l

1.51

571

1321

Other CVD (FINNGEN)

117

156

5.92

58.81

1.5

1.3

6.48

5.37

mmol/l

2.74

108

140

Percutaneous Coronary Intervention

590

1694

2.15

58.79

1.4

1.3

6.91

5.97

mmol/l

11.58

545

1558

Secondary uncertain malignant neoplasm

146

339

4.39

57.44

1.4

6.36

6.76

mmol/l

0.79

139

303

Pleural plaque

111

205

5.54

57.31

1.3

1.2

5.97

7.11

mmol/l

2.77

106

188

Neoplasms

420

891

2.51

56.91

1.4

1.3

6.11

6.34

mmol/l

0.85

388

814

Coronary revascularization (ANGIO or CABG)

585

1695

2.13

56.81

1.4

1.3

6.93

5.97

mmol/l

11.88

541

1559

Emergency coronary revascularization (for ACS)

656

1973

2.03

56.64

1.4

1.3

6.91

6.07

mmol/l

10.08

602

1816

ILD medications: immunosuppressive drugs

438

1779

2.30

56.61

1.4

1.3

6.38

6.25

mmol/l

0.35

406

1642

COPD related to multimorbidity

428

1556

2.35

56.53

1.3

1.4

6.59

6.31

mmol/l

1.04

396

1433

Iron deficiency anaemia

393

1630

2.40

56.24

1.4

6.76

6.25

mmol/l

2.85

365

1496

Presence of cardiac and vascular implants and grafts

466

1532

2.29

56.13

1.4

7.08

6.16

mmol/l

8.17

444

1408

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

231

430

3.41

56.10

1.3

1.2

6.01

5.47

mmol/l

1.93

214

386

Allergic asthma (mode), excluding more controls

104

7.56

56.06

1.2

1.0

6.12

6.47

mmol/l

0.49

Glomerular diseases

210

648

3.30

54.76

1.4

7.84

6.25

mmol/l

7.08

196

596

Atherosclerosis, excluding cerebral and coronary sclerosis

443

1566

2.27

53.04

1.4

7.39

6.17

mmol/l

11.56

403

1453

Major coronary heart disease event

615

1845

2.02

52.38

1.4

1.3

6.93

6.01

mmol/l

11.74

569

1698

Hypo-osmolality and hyponatraemia

196

593

3.34

52.21

1.4

1.3

6.73

6.24

mmol/l

1.41

183

538

Non-Hodgkin lymphoma, all, including Hilmo

138

332

4.23

51.87

1.4

6.22

6.85

mmol/l

1.55

131

299

Parasetamol

487

1102

2.25

51.57

1.4

1.3

6.26

6.18

mmol/l

0.19

456

1018

Infections, IBD-co-morbidities

165

302

3.95

51.12

1.5

1.3

6.58

5.34

mmol/l

4.31

151

277

Undetermined asthma

8.07

50.66

1.4

1.1

5.88

6.84

mmol/l

1.74

Hypertensive Heart Disease

249

674

2.93

50.27

1.4

1.3

7.21

5.62

mmol/l

10.76

232

630

Pacemaker

369

1525

2.35

49.95

1.4

7.02

6.24

mmol/l

6.06

354

1395

Type 2 diabetes, wide definition

602

1945

1.99

49.90

1.4

1.3

8.12

5.55

mmol/l

48.46

557

1791

Ischemic heart diseases

579

1728

2.02

49.33

1.4

1.3

6.89

5.98

mmol/l

10.92

535

1590

Hard cardiovascular diseases

566

1662

2.04

49.31

1.4

1.3

6.92

5.92

mmol/l

10.43

528

1526

Asthma-related infections

454

2098

2.13

49.24

1.3

6.41

6.28

mmol/l

0.43

410

1942

Asthma, hospital admission 2, infections

454

2098

2.13

49.24

1.3

6.41

6.28

mmol/l

0.43

410

1942

Complications of procedures, not elsewhere classified

590

2511

1.96

48.95

1.4

1.3

6.45

6.26

mmol/l

0.89

547

2312

malignant neoplasm of female genital organs

116

253

4.62

48.89

1.2

5.48

6.95

mmol/l

6.35

109

227

Nutritional anaemias

436

1961

2.16

48.64

1.4

6.78

6.26

mmol/l

3.30

405

1811

Glomerular disorders in diseases classified elsewhere

154

424

3.72

48.10

1.4

8.56

6.27

mmol/l

8.99

142

395

Hypertension, essential

477

1249

2.17

48.07

1.4

1.3

6.78

5.63

mmol/l

10.20

436

1151

Chronic lower respiratory diseases

796

2364

1.80

46.70

1.4

1.3

6.36

6.25

mmol/l

0.44

730

2185

Primary_lymphoid and hematopoietic malignant neoplasms

254

957

2.69

46.33

1.4

6.21

6.39

mmol/l

0.49

242

867

Pain in throat and chest

495

1428

2.09

46.11

1.3

6.37

6.11

mmol/l

1.13

453

1311

Insulin medication

479

1973

2.06

45.86

1.4

1.3

9.30

5.55

mmol/l

58.59

442

1822

Complications of medical and surgical care

547

2599

1.95

45.68

1.4

1.3

6.54

6.30

mmol/l

1.12

511

2396

Cardiovascular diseases

247

452

2.95

45.34

1.4

1.2

6.23

5.39

mmol/l

4.31

227

406

Polyarthropathies

535

1759

2.00

45.01

1.4

1.3

6.29

6.35

mmol/l

0.18

495

1622

Care involving use of rehabilitation procedures

405

1736

2.16

44.84

1.3

6.59

6.25

mmol/l

1.35

370

1580

Disorders of lipoprotein metabolism and other lipidaemias

591

1905

1.93

44.61

1.4

1.3

6.93

6.13

mmol/l

6.93

539

1747

Other respiratory disorders and diseases

239

891

2.73

44.57

1.5

1.4

6.63

6.35

mmol/l

0.72

221

813

Other diseases of the respiratory system

239

891

2.73

44.57

1.5

1.4

6.63

6.35

mmol/l

0.72

221

813

Other and unspecified iron deficiency

298

1234

2.44

44.46

1.4

6.84

6.31

mmol/l

2.35

276

1123

Hypertensive diseases

468

1255

2.12

44.18

1.4

1.3

6.75

5.62

mmol/l

10.18

431

1156

Hypertension

467

1255

2.11

43.83

1.4

1.3

6.76

5.62

mmol/l

10.30

430

1156

Major coronary heart disease event excluding revascularizations

482

1575

2.05

43.80

1.4

1.3

7.22

6.03

mmol/l

12.53

441

1449

Diabetic nephropathy, excluding more controls

172

431

3.35

43.67

1.3

9.73

6.81

mmol/l

11.84

157

399

Coronary atherosclerosis

491

1539

2.03

42.89

1.4

1.3

7.12

5.98

mmol/l

13.58

453

1414

Unspecified kidney failure

139

388

3.67

42.61

1.3

1.4

7.01

6.13

mmol/l

2.06

128

355

Codeine

558

1554

1.96

42.58

1.4

1.3

6.37

6.30

mmol/l

0.23

515

1433

Malignant neoplasm of digestive organs

281

893

2.51

42.37

1.3

1.4

6.41

6.67

mmol/l

0.67

262

815

Ulcer of lower limb, not elsewhere classified

179

591

3.09

41.85

1.4

7.59

6.30

mmol/l

4.92

164

542

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

328

958

2.34

41.18

1.3

6.20

6.72

mmol/l

2.29

303

873

Myocardial infarction

405

1346

2.13

41.13

1.4

1.3

7.13

5.99

mmol/l

10.01

370

1237

Allergic asthma (mode)

145

5.43

40.75

1.2

1.1

6.12

6.55

mmol/l

0.73

132

Explicit bacterial Sepsis

124

330

3.83

40.68

1.3

1.4

6.37

6.17

mmol/l

0.30

112

306

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

139

264

3.80

40.59

1.4

1.3

6.70

5.37

mmol/l

4.33

125

242

Certain infectious and parasitic diseases

467

1138

2.06

40.18

1.4

1.3

6.35

6.15

mmol/l

0.74

438

1053

Hyperkalaemia

194

4.84

40.11

1.3

1.4

7.34

6.04

mmol/l

3.29

178

Cardiomyopathy, other and unspecified

167

5.13

40.04

1.4

1.3

6.72

5.67

mmol/l

1.50

149

Gout

307

1190

2.30

39.04

1.4

1.3

6.39

6.40

mmol/l

0.02

290

1082

STROKE

357

1110

2.20

38.96

1.4

1.3

6.89

5.55

mmol/l

10.69

331

1015

Secondary hypertension

118

5.87

37.99

1.4

1.3

6.85

5.26

mmol/l

3.50

107

Calcific aortic valvular stenosis

321

1436

2.19

37.19

1.4

6.99

6.25

mmol/l

4.86

304

1316

Calcific aortic valvular stenosis, operated

321

1436

2.19

37.19

1.4

6.99

6.25

mmol/l

4.86

304

1316

Depression medications

111

119

4.71

36.98

1.4

1.2

5.92

5.09

mmol/l

2.11

101

109

Calcific aortic valvular stenosis, diagnosis (helper)

320

1435

2.19

36.85

1.4

6.99

6.25

mmol/l

4.84

304

1315

Operations 2 for CAVS

320

1435

2.19

36.85

1.4

6.99

6.25

mmol/l

4.84

304

1315

Caries of dentine

208

776

2.64

36.47

1.4

1.3

6.56

6.36

mmol/l

0.39

194

714

Calcific aortic valvular stenosis, including rheumatic fever

320

1440

2.18

36.44

1.4

6.99

6.25

mmol/l

4.83

304

1320

Later onset COPD

319

1162

2.22

36.42

1.4

6.39

6.34

mmol/l

0.11

293

1076

Insulin, combination of fast acting with intermediate-acting or long-acting

480

2347

1.88

36.24

1.4

1.3

9.30

5.83

mmol/l

51.91

442

2163

Other acute lower respiratory infections

400

1924

1.99

36.17

1.3

6.38

6.28

mmol/l

0.26

376

1759

Other disorders of skin and subcutaneous tissue

510

2469

1.85

36.16

1.4

1.3

6.88

6.27

mmol/l

3.73

467

2291

Autoimmune diseases excluding thyroid diseases, strict definition

673

2120

1.75

36.05

1.4

1.3

6.70

6.09

mmol/l

4.66

622

1945

Other malignant neoplasms of skin (=non-melanoma skin cancer)

302

914

2.28

36.02

1.3

6.18

6.73

mmol/l

2.40

279

836

Gout, FINNGEN

307

1410

2.20

35.95

1.4

6.39

6.31

mmol/l

0.19

290

1292

Malignant neoplasm of skin

320

994

2.22

35.84

1.3

6.27

6.71

mmol/l

1.60

294

904

Basal cell carcinoma, including avohilmo

300

916

2.27

35.50

1.4

1.3

6.08

6.75

mmol/l

3.70

274

838

Amputation

135

418

3.30

35.27

1.5

1.3

7.82

6.38

mmol/l

4.66

123

385

Malignant neoplasm of breast, HER2-negative

199

471

2.78

35.22

1.3

1.2

6.35

6.89

mmol/l

2.06

187

431

Dental caries

222

858

2.51

35.22

1.4

1.3

6.57

6.35

mmol/l

0.46

208

786

Malignant neoplasm of breast, HER2-negative, including Hilmo

203

481

2.75

35.07

1.3

1.2

6.27

6.89

mmol/l

2.57

192

439

Malignant neoplasm of breast, including Hilmo

203

481

2.75

35.06

1.3

1.2

6.27

6.89

mmol/l

2.57

192

439

Autoimmune diseases excluding thyroid diseases

687

2188

1.72

34.96

1.4

1.3

6.70

6.11

mmol/l

4.44

636

2008

L04AA Selective immunosuppressants

171

610

2.83

34.73

1.5

1.4

6.73

6.26

mmol/l

0.96

162

562

Malignant neoplasm of breast

199

474

2.75

34.60

1.3

1.2

6.33

6.89

mmol/l

2.12

187

432

Other respiratory diseases principally affecting the interstitium

202

789

2.60

34.47

1.4

6.69

6.39

mmol/l

0.65

186

723

Streptococcal septicaemia

106

285

3.80

34.39

1.3

6.37

6.49

mmol/l

0.13

264

Insulin, intermediate and long-acting

428

2199

1.90

33.93

1.4

1.3

9.51

5.84

mmol/l

50.44

395

2028

Insulin, fast-acting

282

1288

2.21

33.60

1.4

1.3

9.82

5.81

mmol/l

44.17

259

1176

Cardiodefibrillation

338

1660

2.05

33.26

1.5

1.4

6.49

6.30

mmol/l

0.64

317

1529

Nonischemic cardiomyopathy

112

320

3.56

33.15

1.3

6.33

6.12

mmol/l

0.33

102

297

Basal cell carcinoma

290

904

2.24

33.11

1.3

6.11

6.73

mmol/l

3.13

265

826

Diseases of oesophagus, stomach and duodenum

688

2457

1.68

32.93

1.4

1.3

6.33

6.28

mmol/l

0.15

634

2277

Hernia of abdominal wall, postoperative

122

370

3.33

32.81

1.3

6.28

6.20

mmol/l

0.11

115

335

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

162

581

2.84

32.74

1.5

1.4

6.79

6.28

mmol/l

1.18

153

536

Pure hypercholesterolaemia

510

1838

1.82

32.71

1.4

1.3

6.75

6.14

mmol/l

4.25

472

1684

Abnormal findings on examination of blood, without diagnosis

396

1893

1.94

32.64

1.4

6.63

6.28

mmol/l

1.41

362

1746

Myocardial infarction, strict

367

1302

2.02

32.64

1.3

1.4

7.14

5.98

mmol/l

9.22

333

1197

Diabetes, varying definitions

621

2133

1.71

31.77

1.4

1.3

7.68

5.49

mmol/l

42.78

569

1969

Diabetes mellitus

622

2132

1.71

31.69

1.4

1.3

7.67

5.49

mmol/l

43.02

571

1968

Malignant neoplasm of breast, ER-positive, including Hilmo

157

425

2.87

30.81

1.3

1.2

6.44

6.89

mmol/l

1.23

146

387

Other diseases of blood and blood-forming organs, wide

187

746

2.54

30.53

1.4

6.21

6.36

mmol/l

0.30

176

682

Ischaemic heart disease, wide definition

524

1840

1.77

30.51

1.4

1.3

7.00

6.01

mmol/l

11.22

479

1697

Malignant neoplasm of breast, HER-positive

154

421

2.87

30.38

1.3

1.2

6.46

6.86

mmol/l

1.02

143

383

Oedema, not elsewhere classified

239

1050

2.26

30.32

1.4

6.56

6.23

mmol/l

0.88

225

962

Diseases of liver

264

1231

2.16

30.00

1.5

1.3

6.81

6.31

mmol/l

1.95

244

1126

Insulin, fast-acting or short human

284

1362

2.10

29.94

1.4

1.3

9.78

5.99

mmol/l

40.38

261

1244

Type 2 diabetes

608

2106

1.69

29.81

1.4

1.3

7.71

5.50

mmol/l

41.64

557

1942

Diabetes, insulin treatment (Kela reimbursement)

647

2367

1.66

29.52

1.4

1.3

8.13

5.59

mmol/l

54.94

602

2185

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

432

2366

1.81

29.52

1.4

1.3

6.54

6.31

mmol/l

0.82

402

2185

712

2265

1.63

29.40

1.3

6.41

6.24

mmol/l

0.72

665

2103

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

175

313

2.82

29.23

1.3

1.2

6.49

6.18

mmol/l

0.57

159

285

COPD, hospital admissions 1, only main diagnosis

327

1418

1.99

28.98

1.3

1.4

6.46

6.31

mmol/l

0.36

304

1306

Bronchitis

682

2655

1.62

28.97

1.3

6.31

6.27

mmol/l

0.12

641

2445

Diabetic nephropathy

175

689

2.55

28.66

1.3

1.4

9.76

7.31

mmol/l

9.13

160

637

Invasive ventilation

237

3.80

28.58

1.3

1.4

6.87

6.58

mmol/l

0.31

221

Peripheral artery operations in Hilmo

149

550

2.75

28.54

1.4

1.3

7.86

6.24

mmol/l

5.80

134

503

Gout, idiopatic and unspecified

253

1188

2.16

28.39

1.4

6.38

6.29

mmol/l

0.24

238

1083

Implicit fungal Sepsis

200

4.04

27.98

1.5

1.3

7.00

6.44

mmol/l

0.72

188

Hypothyroidism (congenital or acquired)

112

4.35

27.83

1.4

1.2

5.94

5.11

mmol/l

2.93

102

Hyperlipidaemia, other/unspecified

311

1452

1.99

27.80

1.4

1.3

7.12

6.13

mmol/l

5.02

292

1332

Endocrine, nutritional and metabolic diseases

429

1175

1.86

27.69

1.4

1.3

6.72

5.38

mmol/l

13.51

399

1080

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

580

2092

1.68

27.68

1.4

1.3

8.12

5.50

mmol/l

52.27

536

1932

Enterocolitis due to Clostridium difficile

121

408

3.02

27.45

1.5

1.4

6.64

6.53

mmol/l

0.13

106

381

Peripheral arterial reconstruction

197

849

2.36

27.30

1.4

7.79

6.39

mmol/l

6.57

175

775

Other bacterial intestinal infections

160

630

2.57

26.92

1.5

1.4

6.71

6.35

mmol/l

0.74

143

575

Amputation of toe

100

306

3.35

26.82

1.4

1.5

7.98

6.41

mmol/l

3.64

286

Asthma (diagnoses ohter than nonallergic)

549

2756

1.66

26.74

1.4

1.3

6.35

6.29

mmol/l

0.20

504

2552

Type 1 diabetes

173

708

2.46

26.67

1.3

9.87

5.42

mmol/l

27.91

158

643

Iron deficiency anaemia secondary to blood loss (chronic)

150

577

2.63

26.51

1.3

1.4

6.43

6.31

mmol/l

0.21

139

534

Dipeptidyl peptidase 4 (DPP-4) inhibitors

428

1941

1.78

26.47

1.4

1.3

8.28

5.76

mmol/l

31.64

394

1789

Coronary artery bypass grafting

256

905

2.13

26.40

1.4

7.08

6.03

mmol/l

5.16

240

831

Hypothyroidism and >3 levothyroxin purchases

110

4.28

26.38

1.4

1.2

5.88

5.13

mmol/l

2.46

100

Hypothyroidism, levothyroxine purchases

110

4.28

26.38

1.4

1.2

5.88

5.13

mmol/l

2.46

100

Intestinal infectious diseases

585

2730

1.63

26.34

1.4

1.3

6.47

6.25

mmol/l

1.09

534

2526

Dilated cardiomyopathy

136

503

2.75

26.07

1.3

1.4

6.88

6.31

mmol/l

1.16

127

466

Volume depletion

105

338

3.16

25.82

1.4

1.3

6.67

6.12

mmol/l

1.34

308

COPD-related respiratory insufficiency

136

509

2.72

25.48

1.4

6.97

6.46

mmol/l

0.93

125

471

Other interstitial pulmonary diseases

164

672

2.48

25.47

1.4

6.66

6.39

mmol/l

0.48

149

620

Gout, strict definition

195

869

2.28

25.03

1.5

1.4

6.52

6.35

mmol/l

0.47

182

793

Interstitial lung disease

164

679

2.45

24.92

1.4

6.66

6.36

mmol/l

0.54

149

627

Interstitial lung disease endpoints

164

679

2.45

24.92

1.4

6.66

6.36

mmol/l

0.54

149

627

Other bacterial intestinal infections

181

782

2.34

24.88

1.4

6.69

6.38

mmol/l

0.65

162

715

Diseases of the digestive system

354

1944

1.82

24.81

1.4

1.3

6.58

6.31

mmol/l

0.94

333

1792

ILD, hospital admissions

161

663

2.47

24.76

1.4

6.64

6.36

mmol/l

0.47

147

610

Persons with potential health hazards related to communicable diseases

186

808

2.29

24.60

1.3

6.21

6.11

mmol/l

0.20

168

746

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

267

3.38

24.55

1.5

1.3

6.21

6.78

mmol/l

0.74

236

405

2098

1.75

24.54

1.3

1.4

6.24

6.26

mmol/l

0.05

369

1936

Antihypertensive medication - note that there are other indications

235

567

2.20

24.49

1.4

1.2

6.49

5.27

mmol/l

8.48

210

519

Cerebrovascular diseases

530

2281

1.64

24.05

1.4

6.95

6.23

mmol/l

5.32

500

2093

Fungal Sepsis

128

4.58

23.71

1.5

1.4

7.07

6.26

mmol/l

1.07

123

Cough

229

1048

2.08

23.49

1.4

1.3

6.08

6.15

mmol/l

0.13

215

962

Acute bronchitis

296

1543

1.89

23.32

1.3

1.4

6.41

6.34

mmol/l

0.13

282

1410

Alcohol use disorder, Swedish definition

387

2040

1.75

23.30

1.3

6.27

6.25

mmol/l

0.04

352

1881

Diabetes medication

612

2306

1.58

23.06

1.4

1.3

7.91

5.56

mmol/l

45.89

560

2135

Disorders resulting from impaired renal tubular function

116

4.71

22.79

1.5

1.4

7.43

6.50

mmol/l

1.05

109

Type 1 diabetes, wide definition, subgroup 1

133

519

2.58

22.78

1.4

1.3

10.53

5.37

mmol/l

30.74

119

476

Gout, unspecified

205

969

2.14

22.75

1.4

6.49

6.36

mmol/l

0.33

192

879

Diarrhoea and gastroenteritis of presumed infectious origin

428

2297

1.68

22.54

1.3

6.40

6.22

mmol/l

0.61

395

2124

Persons encountering health services in other circumstances, wide

720

2440

1.52

22.53

1.4

1.3

6.50

6.20

mmol/l

1.64

667

2253

Bacterial intestinal infections, IBD co-morbidities

156

661

2.39

22.50

1.5

1.4

6.70

6.38

mmol/l

0.61

139

604

Disorders of gallbladder, biliary tract and pancreas

627

2549

1.56

22.49

1.3

6.70

6.20

mmol/l

3.69

590

2348

Asthma/COPD (KELA code 203)

548

2361

1.60

22.30

1.4

1.3

6.46

6.25

mmol/l

0.88

510

2182

Need for other prophylactic measures

169

3.93

22.27

1.4

6.09

6.52

mmol/l

0.55

157

409

2129

1.70

22.16

1.3

1.4

6.23

6.26

mmol/l

0.06

373

1964

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

387

2266

1.71

22.06

1.3

6.60

6.30

mmol/l

1.16

359

2100

GI-bleeding

275

1463

1.89

21.79

1.5

1.4

6.70

6.30

mmol/l

1.43

257

1345

Malignant neoplasm of urinary organs

253

3.29

21.68

1.3

1.4

6.36

6.82

mmol/l

0.52

226

Abnormalities of heart beat

204

960

2.09

21.56

1.4

1.3

6.57

6.14

mmol/l

1.78

189

884

Fall on same level

654

2333

1.53

21.47

1.3

6.41

6.22

mmol/l

0.90

608

2148

Misadventures to patients during surgical and medical care

120

463

2.62

21.18

1.6

1.4

6.66

6.33

mmol/l

0.62

111

426

Type 2 diabetes, definitions combined

556

2075

1.58

20.95

1.3

7.41

5.50

mmol/l

31.18

512

1915

Disorders of lens

448

1696

1.66

20.73

1.4

1.3

7.00

6.11

mmol/l

6.94

420

1554

ILD, hospital admissions 1, main diag only

142

600

2.40

20.73

1.4

6.64

6.40

mmol/l

0.36

128

555

Pain in limb

499

2088

1.60

20.67

1.3

6.55

6.24

mmol/l

1.53

465

1924

Symptoms and signs involving the urinary system

502

2410

1.59

20.66

1.4

1.3

6.41

6.33

mmol/l

0.26

457

2226

Unspecified acute lower respiratory infection

124

493

2.54

20.58

1.3

1.4

6.17

6.40

mmol/l

0.36

114

453

Type 1 diabetes, wide definition

140

589

2.39

20.46

1.4

1.3

10.36

5.43

mmol/l

30.45

126

537

Substance abuse, excluding more controls

368

1846

1.71

20.23

1.3

1.4

6.12

6.25

mmol/l

0.34

334

1719

Other CVD

187

896

2.11

20.07

1.4

6.59

6.37

mmol/l

0.46

178

815

Type 2 diabetes, strict (exclude DM1)

555

2093

1.56

20.03

1.3

7.41

5.51

mmol/l

31.17

511

1930

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

603

2538

1.53

19.98

1.4

1.3

6.20

6.32

mmol/l

0.52

564

2336

Non-Hodgkin lymphoma, all

125

4.26

19.86

1.5

1.3

5.84

7.28

mmol/l

2.20

117

Other diseases of the digestive system

268

1460

1.85

19.78

1.5

1.4

6.70

6.30

mmol/l

1.37

251

1342

Benign neoplasm of colon, rectum, anus and anal canal

450

2447

1.60

19.49

1.4

1.3

6.85

6.29

mmol/l

3.18

412

2269

Used for control exclusion in common control thyroid runs

616

2044

1.53

19.49

1.4

1.3

6.53

6.07

mmol/l

3.23

568

1875

Intestinal stricture

240

1275

1.90

19.19

1.3

1.4

6.18

6.41

mmol/l

0.58

220

1168

Acute peritonitis

217

3.34

19.16

1.5

1.4

6.99

6.40

mmol/l

0.62

205

Autoimmune diseases

647

2194

1.50

19.13

1.4

1.3

6.51

6.11

mmol/l

2.67

600

2014

Infections of the skin and subcutaneous tissue

342

1998

1.70

19.10

1.4

1.3

6.47

6.20

mmol/l

0.87

313

1824

Codeine or tramadol medication

673

2486

1.49

19.04

1.3

6.47

6.23

mmol/l

1.35

624

2296

Stroke, including SAH

458

2087

1.60

19.03

1.4

1.3

6.92

6.27

mmol/l

3.93

430

1920

Pain, not elsewhere classified

160

737

2.18

18.95

1.3

1.4

6.40

6.28

mmol/l

0.19

142

672

Syncope and collapse

288

1384

1.79

18.76

1.4

6.69

6.24

mmol/l

1.87

268

1274

Fentanyl

352

2.76

18.74

1.5

1.4

5.85

6.47

mmol/l

1.21

316

Emphysema

279

2.99

18.49

1.4

6.42

6.44

mmol/l

0.02

260

316

2.84

18.48

1.3

6.09

6.29

mmol/l

0.30

293

Other disorders of glucose regulation and pancreatic internal secretion

254

3.07

18.29

1.3

1.4

8.92

6.53

mmol/l

3.43

237

Alcoholic liver disease

369

2.70

18.28

1.4

6.61

6.24

mmol/l

0.49

337

Substance abuse

368

2102

1.65

18.23

1.3

6.12

6.28

mmol/l

0.44

334

1939

Coagulation defects, purpura and other haemorrhagic conditions

144

652

2.23

17.89

1.4

6.11

6.35

mmol/l

0.42

136

602

Mental and behavioural disorders due to psychoactive substance use

376

2143

1.63

17.75

1.3

6.15

6.27

mmol/l

0.34

342

1977

All influenza (not pneumonia)

270

2.95

17.58

1.4

1.3

6.61

6.11

mmol/l

0.65

254

Mental and behavioural disorders due to alcohol, excluding acute intoxication

299

1735

1.72

17.53

1.3

1.4

6.08

6.25

mmol/l

0.43

271

1597

Disorders of choroid and retina

528

2480

1.52

17.49

1.4

1.3

7.18

6.19

mmol/l

9.05

494

2286

Paralytic ileus and intestinal obstruction

204

1060

1.94

17.47

1.3

1.4

6.08

6.37

mmol/l

0.72

187

975

Gastroduodenal ulcer

223

1191

1.88

17.45

1.4

1.3

6.61

6.34

mmol/l

0.64

205

1099

246

1347

1.82

17.39

1.3

6.26

6.23

mmol/l

0.06

229

1230

Other soft tissue disorders, not elsewhere classified

548

2127

1.51

17.32

1.3

6.42

6.24

mmol/l

0.75

508

1959

Sequelae of external causes of morbidity and mortality

182

917

2.00

17.09

1.4

1.3

6.94

6.36

mmol/l

1.58

169

843

Type 2 diabetes, definitions combined, including avohilmo

538

2073

1.52

17.06

1.3

7.38

5.50

mmol/l

29.15

495

1911

Injuries to the head

637

2688

1.46

17.03

1.3

6.44

6.25

mmol/l

0.75

586

2487

Non-follicular lymphoma

383

2.60

17.01

1.5

1.4

6.13

6.48

mmol/l

0.62

358

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

298

2.83

17.00

1.5

1.4

7.08

6.63

mmol/l

0.54

282

Stroke, excluding SAH

437

2039

1.57

16.97

1.3

1.4

6.97

6.24

mmol/l

4.46

409

1881

Myocardial infarction, without ST-elevation

337

1863

1.66

16.86

1.3

1.4

7.13

6.26

mmol/l

5.56

313

1719

Fracture of femur

230

1143

1.84

16.51

1.2

1.4

6.65

6.42

mmol/l

0.50

215

1046

Ischaemic Stroke, excluding all haemorrhages

421

2002

1.57

16.45

1.3

1.4

7.03

6.23

mmol/l

5.06

396

1849

Idiopathic gout

103

422

2.48

16.24

1.5

1.4

6.17

6.38

mmol/l

0.38

391

Osteopathies and chondropathies

338

1932

1.64

16.18

1.4

1.3

6.66

6.34

mmol/l

1.19

310

1777

Senile cataract

413

1603

1.59

16.14

1.4

1.3

6.94

6.10

mmol/l

6.17

385

1466

Symptoms and signs involving the digestive system and abdomen

591

2012

1.48

16.01

1.4

1.3

6.43

6.26

mmol/l

0.67

545

1861

Mental and behavioural disorders due to alcohol

330

1945

1.64

15.94

1.3

6.12

6.26

mmol/l

0.37

301

1793

L04AX Other immunosuppressants

309

1868

1.66

15.85

1.4

1.3

5.90

6.35

mmol/l

1.91

283

1729

Agranulocytosis

355

2.59

15.85

1.3

1.4

6.04

6.42

mmol/l

0.62

334

Angina pectoris

355

1459

1.63

15.77

1.4

1.3

6.98

6.02

mmol/l

7.03

326

1342

Nausea and vomiting

174

869

1.97

15.76

1.4

1.3

6.39

6.35

mmol/l

0.06

163

789

Other (not insulin) diabetes medications

560

2258

1.48

15.71

1.3

7.79

5.57

mmol/l

38.33

513

2091

Diabetic retinopathy, excluding more controls

180

500

2.03

15.70

1.3

9.06

6.84

mmol/l

11.50

170

463

Hydronephrosis

358

2.57

15.58

1.3

1.4

6.06

6.02

mmol/l

0.05

331

Early onset COPD

161

804

2.02

15.56

1.3

1.4

6.57

6.33

mmol/l

0.39

151

735

Use of hypnotics and sedatives

619

2465

1.45

15.54

1.3

6.34

6.26

mmol/l

0.30

564

2285

Intestinal infectious diseases

666

2677

1.42

15.45

1.3

6.56

6.23

mmol/l

2.09

613

2478

Injuries to the hip and thigh

336

1887

1.62

15.41

1.3

1.4

6.39

6.34

mmol/l

0.11

316

1741

Convulsions, not elsewhere classified

133

612

2.16

15.37

1.3

1.4

6.66

6.18

mmol/l

0.99

120

556

Hypoglycaemia, other or unspecified

201

3.13

15.24

1.4

1.3

8.93

6.37

mmol/l

3.05

187

Second line medication for Crohn's disease

313

1926

1.63

15.00

1.4

1.3

5.91

6.35

mmol/l

1.89

286

1781

Benign neoplasm: Colon

378

2323

1.56

14.93

1.4

1.3

6.89

6.28

mmol/l

3.02

342

2156

Biguanides

558

2338

1.46

14.89

1.3

7.78

5.75

mmol/l

32.05

512

2162

Other cataract

302

1384

1.66

14.81

1.4

1.3

6.95

6.14

mmol/l

3.73

286

1273

Persons encountering health services for other counselling and medical advice, not elsewhere classified

632

2409

1.43

14.81

1.4

1.3

6.62

6.19

mmol/l

2.42

591

2226

Diseases of the skin and subcutaneous tissue

573

1977

1.46

14.65

1.4

1.3

6.41

6.21

mmol/l

0.79

522

1822

Other disorders of kidney and ureter

111

493

2.28

14.58

1.5

1.4

6.83

6.40

mmol/l

0.72

101

456

Alcohol use disorder, ICD-based

271

1622

1.68

14.55

1.3

6.16

6.27

mmol/l

0.24

243

1489

Exposure to unspecified factor

558

2793

1.44

14.42

1.3

6.48

6.26

mmol/l

0.98

520

2577

Purpura and other haemorrhagic conditions

106

465

2.30

14.33

1.4

5.87

6.48

mmol/l

1.22

100

431

Pneumococcal septicemia

102

4.01

14.21

1.3

5.81

6.30

mmol/l

0.49

Symptoms and signs concerning food and fluid intake

309

2.61

14.20

1.3

1.4

5.98

6.34

mmol/l

0.48

289

Unspecified haematuria

313

1610

1.62

14.19

1.4

6.39

6.29

mmol/l

0.27

291

1483

Hypotension

154

784

1.98

14.17

1.4

6.48

6.43

mmol/l

0.07

145

715

Other retinal disorders

430

2237

1.50

13.93

1.4

1.3

7.39

6.22

mmol/l

9.65

406

2070

Malignant neoplasm of head and neck

212

2.96

13.91

1.5

1.3

5.87

6.93

mmol/l

1.78

190

Other or unspecified ileus, impaction or obstruction

149

755

1.99

13.87

1.3

1.4

6.09

6.40

mmol/l

0.62

135

688

Other diseases of intestines

570

2263

1.44

13.87

1.4

1.3

6.30

6.25

mmol/l

0.14

523

2086

Factors influencing health status and contact with health services

176

450

1.97

13.85

1.4

1.3

6.54

5.97

mmol/l

1.73

164

409

Malignant neoplasm of colon, including Hilmo

115

531

2.18

13.69

1.3

1.4

6.44

6.69

mmol/l

0.38

108

481

Amiodarone users

100

438

2.32

13.64

1.3

1.4

6.90

6.42

mmol/l

0.91

410

Chronic pancreatitis

426

2.33

13.57

1.4

7.21

6.28

mmol/l

1.48

390

Other symptoms and signs involving the circulatory and respiratory systems

149

3.33

13.40

1.3

5.68

6.55

mmol/l

1.10

136

Asthma, including avohilmo

662

2684

1.39

13.31

1.4

1.3

6.27

6.28

mmol/l

0.05

611

2482

Retention of urine

274

1374

1.65

13.25

1.4

6.65

6.26

mmol/l

1.39

249

1266

Colorectal cancer

137

673

2.00

13.05

1.3

1.4

6.53

6.66

mmol/l

0.19

128

610

L02BA Anti-estrogens

379

2.36

12.90

1.3

6.19

6.56

mmol/l

0.71

349

Polyneuropathies and other disorders of the peripheral nervous system

166

896

1.87

12.86

1.3

1.4

6.80

6.33

mmol/l

1.05

153

817

Reimbursement for rheumatic diseases

317

2029

1.56

12.75

1.3

5.99

6.36

mmol/l

1.46

288

1870

Diseases of peritoneum

345

2.43

12.74

1.4

7.07

6.37

mmol/l

0.99

322

Sulfasalazine

154

813

1.90

12.73

1.4

1.3

5.76

6.34

mmol/l

1.58

140

748

Drug-induced neutropenia

218

2.84

12.71

1.3

1.4

5.90

6.46

mmol/l

0.79

203

Asthma, hospital admissions , main diagnosis only

448

2722

1.46

12.68

1.4

1.3

6.35

6.28

mmol/l

0.22

410

2520

Mycoses

169

922

1.84

12.63

1.4

6.46

6.33

mmol/l

0.22

156

847

Constipation

528

2590

1.41

12.34

1.3

6.41

6.33

mmol/l

0.26

487

2394

Abnormal findings on diagnostic imaging of other body structures

387

2.32

12.34

1.6

1.3

6.97

6.51

mmol/l

0.82

366

Unstable angina pectoris

258

1251

1.64

12.14

1.4

7.03

6.06

mmol/l

4.88

238

1153

Sub-endpoint used in defining T1D endpoints

184

1027

1.77

12.05

1.3

1.4

9.92

6.07

mmol/l

24.75

168

941

Osteomyelitis

237

2.70

11.94

1.5

1.4

8.48

6.52

mmol/l

3.61

223

Injuries to the thorax

292

1873

1.56

11.89

1.4

1.3

6.23

6.32

mmol/l

0.20

275

1714

Intracranial trauma

307

1383

1.56

11.88

1.3

6.29

6.08

mmol/l

0.62

284

1267

Cellulitis

143

756

1.90

11.83

1.4

1.3

6.45

6.28

mmol/l

0.28

127

698

L02BG Aromatase inhibitors

151

812

1.87

11.78

1.3

6.36

6.53

mmol/l

0.40

142

759

Injuries to the abdomen, lower back, lumbar spine and pelvis

247

1511

1.62

11.76

1.4

5.97

6.38

mmol/l

1.48

231

1382

Disorders of thyroid, IBD co-morbidities

313

2.23

11.76

1.5

1.2

6.34

5.34

mmol/l

4.25

288

Sequelae with surgical and medical care as external cause

138

725

1.92

11.66

1.4

7.03

6.39

mmol/l

1.72

129

666

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

162

898

1.81

11.55

1.3

1.4

5.97

6.42

mmol/l

0.91

142

831

Presence of other functional implants

372

1735

1.49

11.54

1.4

1.3

6.75

6.17

mmol/l

3.11

351

1595

Rheumatoid arthritis

215

1153

1.68

11.53

1.4

1.3

5.92

6.39

mmol/l

1.36

195

1063

Falls/tendency to fall

570

2057

1.39

11.41

1.4

1.3

6.40

6.21

mmol/l

0.78

527

1889

Diagnoses used for exclusion with ILD

183

1056

1.74

11.39

1.4

6.79

6.36

mmol/l

1.17

171

960

Aortic aneurysm

190

1089

1.72

11.30

1.4

6.06

mmol/l

0.01

174

1010

Rheumatoid arthritis, including avohilmo

227

1391

1.64

11.27

1.4

1.3

5.95

6.38

mmol/l

1.30

206

1277

Other complications of surgical and medical care, not elsewhere classified

274

2.51

11.20

1.4

6.32

6.33

mmol/l

0.01

256

Diverticular disease of intestine

446

1990

1.44

11.19

1.4

1.3

6.37

6.34

mmol/l

0.07

413

1837

Viral infections characterized by skin and mucous membrane lesions

228

1401

1.63

11.14

1.4

1.3

6.29

6.37

mmol/l

0.16

210

1281

Obesity related asthma

188

1100

1.72

11.12

1.4

1.3

6.81

6.30

mmol/l

1.37

166

1013

Medicines for HER+ breast cancer

173

935

1.76

11.11

1.3

6.33

6.54

mmol/l

0.51

162

875

Congenital malformations, deformations and chromosomal abnormalities

261

1582

1.57

10.96

1.4

1.3

6.21

6.24

mmol/l

0.05

246

1449

Seropositive rheumatoid arthritis

164

924

1.78

10.95

1.3

5.96

6.44

mmol/l

1.03

144

848

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

243

2.58

10.85

1.6

1.4

6.86

6.54

mmol/l

0.32

228

Seropositive rheumatoid arthritis, wide

164

936

1.76

10.64

1.3

1.4

5.96

6.41

mmol/l

0.95

144

865

Other/unspecified seropositive rheumatoid arthritis

162

923

1.77

10.58

1.3

1.4

5.97

6.42

mmol/l

0.91

142

854

Gastrointestinal diseases

276

875

1.58

10.56

1.4

1.3

6.33

6.01

mmol/l

1.02

255

806

Seropositive rheumatoid arthritis, strict definition

460

2.10

10.56

1.3

1.4

5.79

6.37

mmol/l

0.73

431

Certain disorders involving the immune mechanism

117

603

1.95

10.51

1.6

1.3

6.99

6.29

mmol/l

1.75

111

558

Osteoporosis

171

924

1.74

10.50

1.4

6.56

6.48

mmol/l

0.13

161

859

Benzodiazepine use

554

2807

1.36

10.41

1.3

6.16

6.32

mmol/l

0.66

498

2611

ILD-related respiratory insufficiency

137

3.14

10.40

1.3

1.4

7.16

6.56

mmol/l

0.42

131

Malignant neoplasm of colon

410

2.16

10.39

1.4

6.47

6.78

mmol/l

0.39

368

Gastric ulcer

138

756

1.84

10.30

1.4

6.59

6.34

mmol/l

0.52

127

693

Acute pancreatitis

134

729

1.85

10.23

1.3

6.99

6.24

mmol/l

1.62

123

665

In situ neoplasms

239

1522

1.58

10.17

1.3

1.4

6.55

6.34

mmol/l

0.40

230

1390

Fracture of lumbar spine and pelvis

155

882

1.77

10.14

1.5

1.4

6.14

6.43

mmol/l

0.55

147

805

Covid-19 suspected case

101

502

2.02

10.06

1.5

1.3

6.58

6.25

mmol/l

0.52

465

Fracture of rib(s), sternum and thoracic spine

202

1240

1.64

10.03

1.3

1.4

6.12

6.35

mmol/l

0.51

191

1127

Persons encountering health services in other circumstances

210

1297

1.62

9.93

1.3

6.49

6.14

mmol/l

0.99

199

1192

Symptoms and signs involving cognition, perception, emotional state and behaviour

533

2679

1.36

9.91

1.3

6.56

6.23

mmol/l

1.87

484

2485

Problems related to lifestyle

254

2.46

9.90

1.3

1.4

6.52

6.14

mmol/l

0.43

234

Autoimmune diseases related-to ILD

446

2753

1.39

9.82

1.4

1.3

6.34

6.28

mmol/l

0.17

417

2545

Congenital malformations, deformations and chromosomal abnormalities

286

1756

1.50

9.76

1.4

1.3

6.16

6.23

mmol/l

0.15

269

1610

Dysphagia

162

946

1.72

9.74

1.4

1.3

6.23

6.31

mmol/l

0.13

152

862

Cholelithiasis, broad definition with cholecystitis

493

2423

1.37

9.74

1.3

6.59

6.21

mmol/l

2.14

462

2232

Genitourinary diseases

314

1047

1.51

9.71

1.4

1.3

6.51

5.76

mmol/l

4.32

289

965

Benign neoplasms

524

2121

1.36

9.64

1.4

1.3

6.38

6.16

mmol/l

0.91

485

1957

Hernia

507

2497

1.36

9.63

1.4

1.3

6.31

6.35

mmol/l

0.14

470

2306

Other disorders of white blood cells

182

2.73

9.60

1.5

6.00

6.59

mmol/l

0.75

168

Unspecified fall

292

1950

1.48

9.31

1.3

6.23

6.32

mmol/l

0.21

272

1791

Hodgkin lymphoma, hilmo

3.75

9.20

1.4

1.3

6.70

6.44

mmol/l

0.27

Candidiasis

142

814

1.75

9.14

1.4

1.3

6.34

6.38

mmol/l

0.06

131

746

Contact with and exposure to communicable diseases

107

559

1.91

9.14

1.3

5.88

6.02

mmol/l

0.32

100

515

Open wound of lower leg

459

2.02

9.13

1.4

6.80

6.38

mmol/l

0.45

422

Other external causes of accidental injury

440

1583

1.40

9.12

1.4

1.3

6.47

6.21

mmol/l

0.94

410

1455

Other and unspecified polyneuropathies, also in other diseases

139

796

1.76

9.02

1.4

6.85

6.30

mmol/l

1.17

129

725

Candidiasis

401

2.08

9.00

1.3

1.4

6.50

6.35

mmol/l

0.18

375

Accidents

438

1583

1.39

8.86

1.4

1.3

6.51

6.21

mmol/l

1.16

409

1455

Thyrotoxicosis

129

727

1.78

8.83

1.5

1.4

6.93

6.39

mmol/l

1.63

121

669

Diarrhoea and gastroenteritis of presumed infectious origin

536

2660

1.33

8.71

1.3

6.44

6.24

mmol/l

0.88

493

2463

Systemic connective tissue disorders

198

1256

1.58

8.65

1.4

1.3

6.52

6.33

mmol/l

0.38

179

1160

Other arthritis (FG)

176

1087

1.63

8.60

1.4

1.3

6.10

6.36

mmol/l

0.64

165

1003

Colorectal adenocarcinoma

107

573

1.87

8.58

1.2

1.4

6.61

6.68

mmol/l

0.07

101

521

Dermatitis

334

2354

1.42

8.53

1.4

1.3

6.27

6.38

mmol/l

0.30

306

2172

Disorders of other endocrine glands

219

1403

1.54

8.49

1.3

6.67

6.37

mmol/l

0.71

201

1289

Use of anticholinesterases

111

1547

0.56

8.37

1.2

1.4

6.25

6.42

mmol/l

0.25

1433

N06DA Anticholinesterases

111

1547

0.56

8.37

1.2

1.4

6.25

6.42

mmol/l

0.25

1433

Thyrotoxicosis, other and/or unspecified

103

552

1.88

8.33

1.5

1.4

6.98

6.37

mmol/l

1.77

503

Acute pancreatitis (for exclusion)

134

778

1.73

8.32

1.3

1.4

6.99

6.32

mmol/l

1.36

123

719

Lung diseases due to external agents

115

641

1.81

8.23

1.3

1.4

6.60

6.43

mmol/l

0.26

106

591

Finngen Rheumatological endpoints

494

2103

1.34

8.18

1.4

1.3

6.23

6.29

mmol/l

0.19

453

1934

malignant neoplasm of male genital organs

177

662

1.64

8.17

1.4

6.25

6.53

mmol/l

0.49

150

603

DVT of lower extremities

127

731

1.75

8.14

1.2

1.4

6.20

6.35

mmol/l

0.22

119

664

Delirium, not induced by alcohol and other psychoactive substances

103

558

1.86

8.05

1.3

1.4

6.67

6.43

mmol/l

0.37

508

Other gastritis (incl. Duodenitis)

141

838

1.69

8.05

1.4

1.3

6.44

6.32

mmol/l

0.20

128

763

Other neurological diseases

431

2512

1.35

8.03

1.4

1.3

6.63

6.32

mmol/l

1.65

409

2311

Open wound of head

315

2149

1.42

8.02

1.4

1.3

6.41

6.24

mmol/l

0.42

291

1974

Cutaneous abscess, furuncle and carbuncle

137

809

1.70

8.00

1.4

1.3

6.66

6.25

mmol/l

0.75

128

748

Phlebitis and thrombophlebitis (not including DVT)

132

777

1.71

7.82

1.3

1.4

6.12

6.37

mmol/l

0.43

124

709

Substance use, excluding alcohol

508

1.88

7.76

1.2

1.4

6.13

6.17

mmol/l

0.04

471

Arterial embolism and thrombosis

215

2.40

7.76

1.3

7.25

6.52

mmol/l

0.70

199

External causes of morbidity and mortality

335

1185

1.42

7.75

1.4

1.3

6.29

6.17

mmol/l

0.30

319

1085

Injury, poisoning and certain other consequences of external causes

278

951

1.47

7.70

1.4

1.3

6.33

6.14

mmol/l

0.49

266

871

Other symptoms and signs involving the urinary system

392

2.01

7.68

1.5

1.3

6.49

6.35

mmol/l

0.14

362

Other noninfective gastroenteritis and colitis

133

788

1.69

7.67

1.2

1.4

6.79

6.30

mmol/l

1.06

121

726

Other antidepressants

576

2274

1.30

7.64

1.3

6.50

6.23

mmol/l

1.23

527

2112

Concussion

248

1379

1.47

7.59

1.4

1.3

6.15

6.08

mmol/l

0.13

228

1263

Sequelae of cerebrovascular disease

254

1504

1.46

7.58

1.3

1.4

6.88

6.22

mmol/l

2.25

243

1377

Poisoning by drugs, medicaments and biological substances

100

550

1.82

7.49

1.2

1.3

6.44

6.10

mmol/l

0.51

514

Malignant melanoma, including Hilmo

447

1.91

7.34

1.5

1.4

6.20

6.72

mmol/l

0.66

404

Intracranial injury

318

2167

1.39

7.33

1.4

1.3

6.44

6.24

mmol/l

0.62

293

2000

Duodenal ulcer

477

1.88

7.28

1.3

1.4

6.75

6.39

mmol/l

0.45

438

Examination and observation for other reasons

324

1340

1.40

7.24

1.4

1.3

6.21

6.07

mmol/l

0.33

302

1238

Supplementary factors related to causes of morbidity and mortality classified elsewhere

161

1018

1.59

7.22

1.3

1.4

6.46

6.28

mmol/l

0.31

145

937

Diabetic retinopathy

231

970

1.49

7.22

1.3

1.4

8.88

7.42

mmol/l

7.08

217

896

Other specified/unspecified arthritis

155

973

1.60

7.18

1.4

1.3

6.10

6.32

mmol/l

0.46

146

902

Noninfective enteritis and colitis

232

1588

1.46

7.13

1.3

6.66

6.26

mmol/l

1.24

216

1451

Other special examinations and investigations of persons without complaint or reported diagnosis

370

1367

1.37

7.13

1.5

1.3

6.37

6.08

mmol/l

1.18

344

1261

Other infectious diseases

328

2.06

7.13

1.6

1.4

6.61

6.53

mmol/l

0.07

306

Other/unspecified rheumatoid arthritis

424

1.92

7.12

1.3

1.4

5.76

6.52

mmol/l

1.25

397

Actinic keratosis

268

1749

1.42

7.05

1.3

1.4

6.34

6.40

mmol/l

0.09

250

1616

Carcinoma in situ of skin of other and unspecified parts of face

392

1.96

7.02

1.3

1.4

6.75

6.56

mmol/l

0.19

364

Other other unspecified disorders of the circulatory system

119

2.82

6.93

1.3

7.07

6.65

mmol/l

0.36

112

Pain (limb, back, neck, head abdominally)

413

1544

1.34

6.90

1.4

1.3

6.50

6.14

mmol/l

1.55

383

1422

Cholelithiasis

455

2404

1.31

6.70

1.3

6.61

6.22

mmol/l

2.19

425

2215

Other viral diseases

123

741

1.66

6.66

1.3

6.52

6.26

mmol/l

0.34

110

690

Tuberculosis

270

2.13

6.65

1.3

1.4

5.98

6.57

mmol/l

0.72

254

Malignant neoplasm, without specification of site

3.08

6.64

1.1

1.3

7.27

7.08

mmol/l

0.08

Type of accident

149

946

1.58

6.62

1.3

1.4

6.41

6.29

mmol/l

0.16

134

870

Skin changes due to chronic exposure to nonionizing radiation

270

1779

1.41

6.61

1.3

1.4

6.35

6.39

mmol/l

0.07

251

1643

280

1846

1.40

6.59

1.3

1.4

6.37

6.38

mmol/l

0.00

260

1705

Status post-ami

181

908

1.53

6.59

1.4

6.77

6.00

mmol/l

3.19

168

839

Chronic nephritic syndrome

117

2.77

6.56

1.8

1.3

6.91

6.50

mmol/l

0.22

110

Abdominal and pelvic pain

516

2012

1.29

6.54

1.4

1.3

6.44

6.26

mmol/l

0.66

476

1861

Malignant neoplasm of bladder, including Hilmo

413

1.89

6.52

1.4

6.87

6.63

mmol/l

0.29

378

Other and unspecified dermatitis

266

1903

1.40

6.51

1.4

1.3

6.25

6.33

mmol/l

0.20

244

1754

Sulfonylureas

254

1430

1.42

6.46

1.4

9.14

5.71

mmol/l

25.61

236

1323

Use of rivastigmine

766

0.40

6.45

1.2

1.4

7.02

6.51

mmol/l

0.37

706

Personality disorders, excluding more controls

525

1.78

6.44

1.2

1.3

6.45

6.13

mmol/l

0.38

490

Viral infections characterized by skin and mucous membrane lesions

428

2809

1.30

6.44

1.4

1.3

6.26

6.28

mmol/l

0.06

399

2591

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

104

604

1.72

6.44

1.3

1.4

6.45

6.22

mmol/l

0.31

567

Embolic stroke with flimmer

3.07

6.37

1.3

8.15

6.57

mmol/l

0.80

Respiratory tuberculosis, confirmed and not-confirmed

229

2.21

6.36

1.4

1.5

5.83

6.51

mmol/l

0.82

215

Respiratory tuberculosis

229

2.21

6.36

1.4

1.5

5.83

6.51

mmol/l

0.82

215

Chronic gastritis

172

1139

1.52

6.35

1.3

6.28

6.39

mmol/l

0.21

165

1049

Thoracic aortic aneurysm

566

1.74

6.33

1.4

1.3

5.96

6.23

mmol/l

0.58

523

Other skin changes

115

695

1.66

6.28

1.3

1.4

6.60

6.35

mmol/l

0.49

108

637

Malignant neoplasm of prostate

168

652

1.55

6.26

1.4

6.25

6.52

mmol/l

0.48

142

593

Malignant melanoma

359

1.93

6.22

1.4

6.44

6.81

mmol/l

0.34

323

Other functional intestinal disorders

249

1650

1.40

6.13

1.4

1.3

6.50

6.35

mmol/l

0.36

227

1524

Mycoses

421

2827

1.30

6.12

1.3

6.36

6.27

mmol/l

0.25

391

2612

Dentofacial anomalies [including malocclusion]

133

1664

0.64

6.11

1.3

5.87

6.25

mmol/l

1.23

127

1535

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

334

1.95

6.08

1.2

1.3

6.16

6.20

mmol/l

0.03

314

Fracture of lower leg, including ankle

277

2004

1.37

5.99

1.3

6.64

6.31

mmol/l

1.01

254

1845

Other viral diseases

144

922

1.55

5.99

1.3

6.49

6.17

mmol/l

0.56

130

848

Cholecystitis

561

1.72

5.96

1.3

1.4

6.39

6.35

mmol/l

0.06

511

Poisoning by medicine

487

1.77

5.94

1.2

1.3

6.42

6.15

mmol/l

0.33

453

Other infectious diseases

283

2.03

5.91

1.6

1.4

6.37

6.60

mmol/l

0.23

264

Systemic lupus erythematosus, unspecified

3.32

5.88

1.5

1.2

7.31

6.94

mmol/l

0.17

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

346

1.92

5.86

1.5

1.4

6.12

6.43

mmol/l

0.42

320

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

155

1023

1.52

5.84

1.4

1.3

6.67

6.29

mmol/l

1.24

142

951

Chronic apical periodontitis

575

2623

1.25

5.83

1.3

6.42

6.27

mmol/l

0.60

533

2424

Acute upper respiratory infections of multiple and unspecified sites

361

2032

1.32

5.82

1.4

1.3

6.44

6.22

mmol/l

0.66

338

1868

Essential (haemorrhagic) thrombocythaemia

3.10

5.78

1.1

1.4

7.00

7.10

mmol/l

0.06

Soft tissue disorders

525

2142

1.26

5.74

1.4

1.3

6.39

6.23

mmol/l

0.60

478

1973

Neurological diseases, wide definition

117

353

1.67

5.74

1.4

1.3

6.12

5.31

mmol/l

3.41

110

323

Transient ischemic attack

325

1979

1.33

5.70

1.4

6.69

6.25

mmol/l

2.33

305

1830

Malignant neoplasm of prostate, including Hilmo

169

668

1.51

5.67

1.4

6.10

6.55

mmol/l

1.15

145

609

Noninfectious colitis NAS

408

1.82

5.63

1.2

1.4

6.96

6.45

mmol/l

0.74

381

Tuberculosis, IBD comorbidity

303

1.97

5.59

1.4

5.91

6.66

mmol/l

1.08

285

Alcohol dependence

154

1034

1.50

5.40

1.3

1.4

6.20

6.29

mmol/l

0.14

138

947

Benign neoplasm: Ascending colon

563

1.68

5.39

1.6

1.4

6.60

6.37

mmol/l

0.35

520

Periodontitis

500

2671

1.25

5.38

1.4

1.3

6.19

6.33

mmol/l

0.51

461

2474

Chronic periodontitis, including avohilmo

498

2666

1.25

5.36

1.4

1.3

6.20

6.33

mmol/l

0.43

459

2470

Specific personality disorders

497

1.72

5.30

1.3

6.51

6.11

mmol/l

0.49

462

Other nutritional deficiencies

288

2033

1.34

5.30

1.3

6.75

6.26

mmol/l

2.11

265

1876

SLE, strict definition

3.01

5.27

1.5

1.2

7.30

6.77

mmol/l

0.30

SLE, ICD10

3.01

5.27

1.5

1.2

7.30

6.77

mmol/l

0.30

Other (seronegative) rheumatoid arthritis, wide

104

643

1.63

5.27

1.3

1.4

5.82

6.47

mmol/l

1.45

597

Chronic periodontitis, complicated

291

2171

1.33

5.26

1.3

6.24

6.32

mmol/l

0.17

265

2005

Idiopathic pulmonary fibrosis

360

1.85

5.25

1.5

1.4

6.08

6.50

mmol/l

0.51

341

Other and unspecified local infections of skin and subcutaneous tissue

296

1.94

5.24

1.5

1.4

6.41

6.38

mmol/l

0.03

276

Diseases of the eye and adnexa

362

1388

1.31

5.21

1.4

1.3

6.30

5.94

mmol/l

1.50

332

1282

Diseases of the musculoskeletal system and connective tissue

268

984

1.37

5.20

1.4

1.3

6.32

6.16

mmol/l

0.38

249

908

Volvulus

2.72

5.20

1.3

1.4

5.76

7.05

mmol/l

1.50

Statin medication

302

1272

1.34

5.17

1.4

1.3

6.80

5.68

mmol/l

8.22

276

1170

Other disorders of skin and subcutaneous tissue, not elsewhere classified

510

1.70

5.13

1.4

7.49

6.33

mmol/l

2.15

472

Insulin, fast-acting (human)

377

1.81

5.11

1.4

1.3

10.90

5.77

mmol/l

14.82

349

Chronic diseases of tonsils and adenoids

197

1739

0.71

5.06

1.3

5.99

6.32

mmol/l

1.10

185

1610

Sleep apnoea

482

2500

1.25

5.06

1.3

6.46

6.26

mmol/l

0.75

441

2322

Pneumonitis due to solids and liquids

358

1.83

5.02

1.3

1.4

6.66

6.56

mmol/l

0.09

332

Bicuspidal aortic valve syndrome

2.72

5.02

1.2

1.4

6.23

6.47

mmol/l

0.26

Vascular disorders of the intestines

280

1.95

5.01

1.5

1.4

6.45

mmol/l

0.00

262

Disorder of lipoprotein metabolism, unspecified

484

1.70

4.99

1.4

1.3

7.11

6.05

mmol/l

2.16

440

Tuberculosis, wide

316

1.88

4.98

1.4

5.91

6.65

mmol/l

1.06

297

Other local infections of skin and subcutaneous tissue

323

1.87

4.97

1.5

1.4

6.44

6.33

mmol/l

0.10

301

Diabetic retinopathy, strict definition

111

624

1.58

4.93

1.4

10.05

7.31

mmol/l

11.20

103

569

Systemic lupus erythematosus

2.80

4.89

1.5

1.2

7.33

6.64

mmol/l

0.44

Tubulo-interstitial nephritis, not specified as acute or chronic

194

2.13

4.88

1.5

1.4

7.85

6.21

mmol/l

2.14

179

Umbilical hernia

148

1008

1.47

4.88

1.2

1.3

6.82

6.31

mmol/l

1.11

137

919

Other reaction to severe stress, and adjustment disorders

128

846

1.52

4.87

1.4

1.3

6.42

6.19

mmol/l

0.43

118

779

Viral and other specified intestinal infections

440

1.71

4.81

1.3

6.45

6.32

mmol/l

0.17

408

Paracetamol or NSAID medication

264

1.70

4.78

1.3

1.4

6.41

6.51

mmol/l

0.11

250

Use of donepezil

1050

0.57

4.78

1.2

1.4

6.06

6.44

mmol/l

0.49

967

Psychiatric diseases

519

2104

1.24

4.78

1.3

6.36

6.26

mmol/l

0.34

472

1964

Acute sinusitis

213

1438

1.37

4.74

1.3

6.00

6.21

mmol/l

0.40

195

1323

Zoster [herpes zoster]

108

693

1.57

4.73

1.4

6.16

6.40

mmol/l

0.45

103

635

Fracture of foot, except ankle

105

669

1.57

4.73

1.3

6.54

6.23

mmol/l

0.56

621

Open wound of ankle and foot

300

1.88

4.73

1.3

1.4

7.10

6.24

mmol/l

1.55

277

Abdominal aortic aneurysm (AAA)

519

1.65

4.70

1.4

6.19

6.07

mmol/l

0.16

482

Abnormal serum enzyme levels

203

1438

1.38

4.67

1.3

1.4

6.34

6.23

mmol/l

0.22

184

1329

Exclusions for E4_PCOS_CONSORTIUM

266

1249

1.34

4.67

1.2

1.3

6.26

6.37

mmol/l

0.27

240

1167

Colectomy operation

105

672

1.57

4.66

1.2

1.4

6.61

6.38

mmol/l

0.32

624

Abnormalities of gait and mobility

505

1.65

4.55

1.3

1.4

6.97

6.50

mmol/l

0.71

472

Disease of hard tissues of teeth, NOS

193

1392

0.72

4.54

1.4

1.3

6.16

6.34

mmol/l

0.40

176

1281

Cardiomyopathies, Secondary/extrinsic

6.89

4.51

1.3

1.5

6.58

5.61

mmol/l

—

Persons encountering health services for examination and investigation

350

1367

1.29

4.50

1.4

1.3

6.31

6.08

mmol/l

0.77

323

1261

Viral and other specified intestinal infections

607

1.58

4.50

1.3

6.45

6.25

mmol/l

0.35

556

Other disorders of veins

194

1403

1.38

4.46

1.3

5.99

6.38

mmol/l

1.18

185

1289

Zoster [herpes zoster]

263

1972

1.32

4.45

1.4

1.3

6.37

6.40

mmol/l

0.08

252

1822

Weight loss

351

1.78

4.42

1.3

1.4

5.91

6.43

mmol/l

0.68

328

Disorders of adult personality and behaviour

618

1.57

4.40

1.3

6.42

6.12

mmol/l

0.37

571

Alzheimer disease, including avohilmo

148

1481

0.70

4.36

1.3

1.4

6.28

6.41

mmol/l

0.23

128

1377

Benign neoplasm: Colon, unspecified

155

1091

1.43

4.35

1.4

6.81

6.37

mmol/l

1.10

134

993

Other diseases of liver

544

1.61

4.29

1.4

6.64

6.33

mmol/l

0.50

505

Any mental disorder

563

2330

1.21

4.28

1.3

6.33

6.30

mmol/l

0.10

507

2181

Personality disorders

591

1.58

4.27

1.2

1.3

6.45

6.15

mmol/l

0.36

545

Fracture of shoulder and upper arm

185

1346

1.38

4.25

1.3

6.72

6.40

mmol/l

0.66

172

1237

Dizziness and giddiness

389

2477

1.25

4.20

1.4

1.3

6.64

6.27

mmol/l

1.87

358

2298

Complications of internal orthopaedic prosthetic devices, implants and grafts

129

884

1.47

4.19

1.4

1.3

6.87

6.38

mmol/l

1.05

124

807

Degeneration of macula and posterior pole

301

1868

1.29

4.19

1.4

6.58

6.26

mmol/l

1.11

286

1729

Hernia of abdominal wall

242

1842

1.32

4.17

1.3

6.61

6.31

mmol/l

0.83

225

1684

Intestinal adhesions without obstruction

299

1.82

4.16

1.2

1.4

6.26

6.42

mmol/l

0.23

277

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

104

683

1.53

4.15

1.3

6.45

6.11

mmol/l

0.55

632

Unspecific neurodegenerative disorder

179

1670

0.73

4.13

1.2

1.4

6.24

6.40

mmol/l

0.33

159

1558

Dorsalgia

497

2185

1.22

4.13

1.3

6.51

6.20

mmol/l

1.50

455

2021

Cardiomyopathy due to drugs and other external agents

10.85

4.10

1.3

1.1

6.97

6.27

mmol/l

—

Diaphragmatic hernia

197

1464

1.35

4.02

1.4

1.3

6.24

6.37

mmol/l

0.27

178

1347

Dementia in Alzheimer disease

839

0.59

3.98

1.2

1.4

6.35

6.50

mmol/l

0.20

786

Other specified and unspecified personality disorders

190

2.01

3.97

1.2

1.4

5.92

6.22

mmol/l

0.24

175

Injuries to the elbow and forearm

317

2206

1.26

3.97

1.2

1.3

6.43

6.34

mmol/l

0.20

299

2025

Superficial injury of head

118

804

1.47

3.96

1.3

1.4

6.38

6.28

mmol/l

0.10

108

736

Exclusions for E4_PCOS_BROAD

470

1.62

3.94

1.2

1.4

6.44

6.35

mmol/l

0.10

438

Methotrexate

387

1.69

3.91

1.3

5.94

6.37

mmol/l

0.44

361

Suicide or other Intentional self-harm

629

1.53

3.90

1.3

6.51

6.17

mmol/l

0.51

584

Other diseases of arteries and capillaries

284

1.81

3.88

1.3

7.37

6.48

mmol/l

1.09

264

Benign neoplasm: Rectum, anus and anal canal

120

826

1.46

3.85

1.4

6.64

6.32

mmol/l

0.74

110

756

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

12.58

3.81

1.3

1.0

5.08

7.32

mmol/l

—

Obesity due to excess calories

191

1430

1.34

3.73

1.3

6.81

6.20

mmol/l

2.27

172

1319

Benign neoplasm: Sigmoid colon

111

758

1.47

3.73

1.4

6.62

6.32

mmol/l

0.59

101

697

Listeriosis

5.86

3.71

1.6

1.3

6.18

6.34

mmol/l

—

Obesity

260

1962

1.28

3.67

1.3

6.88

6.23

mmol/l

3.07

237

1813

General examination and investigation of persons without complaint and reported diagnosis

328

1363

1.26

3.65

1.4

1.3

6.54

6.08

mmol/l

2.26

299

1257

Carcinoma in situ of skin of scalp and neck

123

2.23

3.64

1.3

1.5

7.61

6.43

mmol/l

0.39

116

Obesity and other hyperalimentation

261

1971

1.28

3.63

1.3

6.87

6.23

mmol/l

3.05

238

1822

Carcinoma in situ of skin of upper limb, including shoulder

104

2.34

3.62

1.1

1.3

7.35

6.58

mmol/l

0.22

Fracture of forearm

243

1729

1.29

3.61

1.2

1.3

6.48

6.33

mmol/l

0.37

231

1592

Right hemicolectomy

241

1.84

3.57

1.3

1.4

6.06

6.74

mmol/l

0.85

226

Other and unspecified nonorganic psychotic disorders

421

1.62

3.55

1.3

1.4

5.78

6.20

mmol/l

0.57

395

Symptoms and signs involving the nervous and musculoskeletal systems

286

2274

1.26

3.55

1.3

6.38

6.29

mmol/l

0.24

267

2098

Other condition

414

1.62

3.54

1.3

1.4

6.00

6.37

mmol/l

0.44

385

Sleep apnoea, including avohilmo

491

2542

1.20

3.53

1.3

6.45

6.26

mmol/l

0.73

453

2359

Other and unspecified tonsillitis

103

589

1.47

3.45

1.4

1.3

5.81

6.12

mmol/l

0.56

540

Obesity, other/unspecified

130

930

1.40

3.41

1.4

1.3

6.73

6.26

mmol/l

1.01

118

861

Retinal vascular disorders

522

1.54

3.38

1.4

6.80

6.31

mmol/l

0.69

479

Other strabismus

544

1.52

3.36

1.5

1.4

6.11

6.30

mmol/l

0.33

508

Schizophrenia or delusion, excluding more controls

118

824

1.42

3.36

1.2

1.3

6.04

6.31

mmol/l

0.43

103

762

Retinal vascular occlusion

508

1.54

3.33

1.5

1.4

6.85

6.31

mmol/l

0.78

467

Procreative management

107

617

1.45

3.31

1.2

1.3

6.25

6.20

mmol/l

0.07

101

561

Fluid overload

8.96

3.30

1.2

1.7

7.17

6.59

mmol/l

—

Other blood glucose lowering drugs, excl. Insulins

631

1.48

3.28

1.4

7.93

5.79

mmol/l

7.06

574

Other viral diseases, not elsewhere classified

493

1.54

3.26

1.3

1.4

5.99

6.31

mmol/l

0.49

460

Other systemic involvement of connective tissue (FG)

127

902

1.39

3.24

1.3

6.26

6.46

mmol/l

0.35

116

827

Inguinal hernia

324

1760

1.23

3.20

1.4

1.3

6.12

6.32

mmol/l

0.60

303

1614

Spondylopathies

417

2074

1.20

3.17

1.3

6.37

6.25

mmol/l

0.32

384

1917

Other systemic involvement of connective tissue

133

969

1.38

3.17

1.3

1.4

6.20

6.38

mmol/l

0.32

122

897

Benign neoplasm of other and ill-defined parts of digestive system

653

1.46

3.15

1.3

1.4

6.62

6.43

mmol/l

0.33

602

Disorders of parathyroid gland

109

759

1.42

3.15

1.4

6.66

6.47

mmol/l

0.24

101

701

Other symptoms and signs involving cognitive functions and awareness

263

1915

1.25

3.14

1.3

1.4

6.54

6.28

mmol/l

0.82

237

1778

Benign neoplasm: Rectum

104

729

1.43

3.11

1.4

6.62

6.33

mmol/l

0.65

667

Sequelae of injuries, of poisoning and of other consequences of external causes

103

721

1.43

3.10

1.4

6.28

6.30

mmol/l

0.02

665

Disorders of ocular muscles, binocular movement, accommodation and refraction

182

1386

1.30

3.04

1.4

1.3

6.24

6.23

mmol/l

0.02

166

1271

Other diseases of oesophagus

363

1.61

2.97

1.7

1.3

6.00

6.49

mmol/l

0.97

341

Chronic tubulo-interstitial nephritis

2.29

2.94

1.4

7.07

6.54

mmol/l

0.54

Other and unspecified injuries of head

213

1.79

2.91

1.2

1.4

6.78

6.54

mmol/l

0.21

199

Injuries to the knee and lower leg

572

2734

1.16

2.91

1.3

6.59

6.22

mmol/l

2.15

526

2530

Dental operations

372

1587

1.21

2.87

1.4

1.3

6.23

6.39

mmol/l

0.57

343

1453

Disorders of skin appendages

185

1437

1.29

2.85

1.5

1.3

6.20

6.27

mmol/l

0.12

175

1317

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

577

1.46

2.85

1.4

1.3

6.24

6.16

mmol/l

0.09

529

Panic disorder

252

1.71

2.83

1.3

6.14

6.35

mmol/l

0.17

232

Abnormal weight loss

329

1.62

2.83

1.3

1.4

5.92

6.45

mmol/l

0.61

308

Episodal and paroxysmal disorders

527

2299

1.17

2.82

1.3

6.36

6.20

mmol/l

0.67

476

2122

Palmar fascial fibromatosis [Dupuytren]

103

736

1.41

2.81

1.4

1.3

6.89

6.23

mmol/l

0.98

673

Other viral diseases, not elsewhere classified

658

1.42

2.78

1.3

6.07

6.23

mmol/l

0.24

607

Use of memantine

115

1295

0.73

2.78

1.2

1.4

6.41

6.39

mmol/l

0.02

1209

Use of other anti-dementia drugs

115

1295

0.73

2.78

1.2

1.4

6.41

6.39

mmol/l

0.02

1209

Schizophrenia or delusion

118

864

1.37

2.77

1.2

1.3

6.04

6.31

mmol/l

0.43

103

798

Fibroblastic disorders

134

1004

1.34

2.73

1.4

1.3

6.77

6.22

mmol/l

1.08

126

919

Low back pain

357

2143

1.20

2.73

1.3

6.55

6.21

mmol/l

1.21

326

1982

Gastro-oesophageal reflux disease

317

2267

1.21

2.72

1.4

1.3

6.23

6.33

mmol/l

0.18

291

2103

Injuries to the ankle and foot

275

1999

1.22

2.71

1.3

6.64

6.21

mmol/l

1.51

251

1841

Gonarthrosis, primary, with knee surgery

229

2261

0.80

2.71

1.4

1.3

6.32

6.35

mmol/l

0.06

216

2082

Cholecystectomy

353

2551

1.19

2.71

1.3

6.75

6.30

mmol/l

1.89

330

2361

Schizophrenia, schizotypal and delusional disorders

118

868

1.36

2.71

1.2

1.3

6.05

6.32

mmol/l

0.42

103

803

Heartburn

302

1.63

2.70

1.4

6.87

6.42

mmol/l

0.50

278

Other dorsopathies, not elsewhere classified

488

2186

1.17

2.70

1.3

6.31

6.20

mmol/l

0.35

444

2021

Disorders of eyelid, lacrimal system and orbit

423

2731

1.18

2.69

1.3

6.53

6.31

mmol/l

0.85

394

2522

Hyperparathyroidism

659

1.41

2.69

1.4

6.67

6.49

mmol/l

0.20

607

Papillary adenocarcinoma of thyroid gland

2.34

2.65

1.4

1.2

5.82

6.94

mmol/l

1.13

Spondyloarthritis

594

1.43

2.64

1.4

6.20

6.35

mmol/l

0.21

551

Disorders of the thyroid gland

461

2572

1.17

2.62

1.4

1.3

6.43

6.29

mmol/l

0.50

435

2364

Fall involving bed

127

1.99

2.61

1.2

1.4

7.30

6.58

mmol/l

0.50

121

Speech therapy

127

952

1.34

2.60

1.6

1.3

6.63

6.36

mmol/l

0.48

118

871

Anxiety (asthma-related co-morbidities)

207

1274

1.26

2.60

1.3

6.32

6.21

mmol/l

0.20

186

1186

Other anxiety disorders

147

973

1.31

2.58

1.3

6.28

6.22

mmol/l

0.09

131

895

Other and unspecified vascular occlusions

393

1.53

2.58

1.6

1.4

6.73

6.42

mmol/l

0.30

363

Other/unspecified dorsalgia

174

1351

1.28

2.58

1.4

1.3

6.08

6.28

mmol/l

0.47

157

1252

Herpesviral [herpes simplex] infections

597

1.43

2.58

1.2

1.4

6.46

6.33

mmol/l

0.16

548

Injury of nerves and spinal cord at thorax level

7.30

2.56

1.4

1.1

7.20

6.97

mmol/l

—

Combinations of oral blood glucose lowering drugs

147

1129

1.31

2.55

1.3

8.31

5.69

mmol/l

13.68

135

1036

Other necrotizing vasculopathies

261

1.66

2.54

1.7

1.4

6.85

6.60

mmol/l

0.20

245

Primary gonarthrosis, bilateral

196

2098

0.80

2.53

1.4

1.3

6.24

6.34

mmol/l

0.20

186

1934

Melanocytic naevi

119

888

1.34

2.52

1.3

1.4

6.31

6.29

mmol/l

0.03

111

817

Acute suppurative otitis media

459

1.47

2.50

1.3

1.4

5.98

6.03

mmol/l

0.06

424

Headache

236

1530

1.23

2.50

1.3

6.62

6.22

mmol/l

1.46

221

1408

Urticaria and erythema

135

1028

1.32

2.49

1.3

6.24

6.28

mmol/l

0.08

120

949

Symptoms and signs involving the skin and subcutaneous tissue

325

2674

1.19

2.47

1.4

1.3

6.12

6.35

mmol/l

0.98

307

2465

Other and unspecified effects of external causes

713

1.38

2.44

1.3

7.09

6.25

mmol/l

1.61

659

Leisure time condition

579

1.42

2.44

1.3

1.4

6.71

6.30

mmol/l

0.51

540

Embolic stroke

211

1.72

2.43

1.3

1.4

7.42

6.33

mmol/l

0.80

199

Infections with a predominantly sexual mode of transmission

587

1.41

2.42

1.2

1.3

6.44

6.12

mmol/l

0.43

544

Other follicular disorders

167

1.80

2.40

1.3

1.4

6.80

6.35

mmol/l

0.49

153

Myocardial infarction, with ST-elevation

116

871

1.34

2.39

1.4

6.92

6.41

mmol/l

1.19

105

786

Diseases of pulp and periapical tissues, including avohilmo

525

2366

1.15

2.38

1.3

6.27

6.29

mmol/l

0.06

484

2189

Epilepsy

150

1165

1.29

2.36

1.3

1.4

6.26

6.25

mmol/l

0.01

135

1069

Hypothyroidism, strict autoimmune

331

1835

1.19

2.34

1.3

6.34

6.14

mmol/l

0.67

314

1688

Alzheimer disease

142

1336

0.78

2.34

1.3

1.4

6.41

mmol/l

0.00

120

1248

Infective dermatitis

395

1.50

2.32

1.4

6.34

6.31

mmol/l

0.02

367

Medical observation and evaluation for suspected diseases and conditions

319

1367

1.19

2.32

1.4

1.3

6.30

6.08

mmol/l

0.60

294

1261

Dermatophytosis

494

1.44

2.31

1.4

6.18

6.40

mmol/l

0.25

461

Barrett oesophagus

177

1.76

2.30

1.3

1.4

5.77

6.50

mmol/l

1.34

165

Superficial injury of hip and thigh

545

1.42

2.28

1.6

1.4

5.83

6.35

mmol/l

1.33

496

Functional dyspepsia

109

817

1.34

2.28

1.3

6.17

6.36

mmol/l

0.32

752

Neurological diseases

394

1693

1.17

2.26

1.4

1.3

6.33

6.15

mmol/l

0.59

360

1566

Unspecified nephritic syndrome

2.30

2.25

1.3

5.91

5.94

mmol/l

0.01

Other and specified injuries of hip and thigh

2.30

2.25

1.3

7.12

6.27

mmol/l

0.55

Other diseases of urinary system

495

2425

1.15

2.25

1.4

1.3

6.32

6.28

mmol/l

0.11

453

2241

Alzheimer’s disease (undefined), excluding more controls

0.00

2.24

0.0

1.4

—

6.46

—

Ulcer of oesophagus

271

1.60

2.23

1.5

1.3

6.43

mmol/l

0.00

253

Superficial injury of abdomen, lower back and pelvis

448

1.45

2.23

1.4

5.29

6.48

mmol/l

2.76

414

Viral warts

232

1.64

2.23

1.4

6.03

6.45

mmol/l

0.46

215

Serous carcinoma of ovary

5.64

2.22

1.4

1.2

5.22

8.03

mmol/l

—

Hidradenitis suppurativa

2.35

2.22

1.3

1.2

6.34

6.43

mmol/l

0.05

Caries of dentine, including avohilmo

432

1905

1.16

2.22

1.4

1.3

6.20

6.36

mmol/l

0.54

391

1756

!Aliquae complicationes praecoces traumatis

128

1.89

2.21

1.5

1.3

6.64

6.49

mmol/l

0.08

120

Early complications of trauma

128

1.89

2.21

1.5

1.3

6.64

6.49

mmol/l

0.08

120

Other disorders of urethra and urinary system

342

2102

1.18

2.20

1.3

6.45

6.28

mmol/l

0.48

314

1950

Degenerative diseases of the nervous system

161

1481

0.80

2.15

1.3

1.4

6.30

6.40

mmol/l

0.18

137

1376

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

237

1910

1.21

2.14

1.4

1.3

5.89

6.31

mmol/l

1.51

219

1762

Diseases of oral cavity, salivary glands and jaws

353

1548

1.17

2.14

1.4

1.3

6.33

6.35

mmol/l

0.04

325

1423

Unspecified chronic bronchitis

116

1.91

2.11

1.5

6.11

6.54

mmol/l

0.42

109

Keratitis

149

1181

1.26

2.08

1.2

1.3

6.44

6.33

mmol/l

0.18

135

1082

Dementia, including avohilmo

212

1767

0.82

2.08

1.2

1.4

6.40

6.38

mmol/l

0.03

191

1649

190

1348

1.23

2.05

1.3

1.4

6.72

6.31

mmol/l

1.11

180

1241

Status epilepticus

132

1.83

2.04

1.2

1.3

6.63

6.67

mmol/l

0.02

122

All anxiety disorders

207

1344

1.22

2.03

1.3

6.32

6.23

mmol/l

0.17

186

1241

Arthropathies

417

1835

1.15

2.00

1.4

1.3

6.28

6.31

mmol/l

0.06

380

1689

Caries of enamel

265

2261

0.84

1.99

1.3

6.13

6.29

mmol/l

0.44

253

2079

Alzheimer’s disease, strict definition

110

1172

0.77

1.98

1.3

1.4

6.54

6.42

mmol/l

0.18

1094

Strabismus

100

757

1.32

1.97

1.4

1.3

6.17

6.31

mmol/l

0.24

696

Other diseases of anus and rectum

151

1206

1.25

1.96

1.3

1.4

6.32

6.37

mmol/l

0.09

139

1107

Retinal detachments and breaks

189

1551

1.22

1.96

1.3

6.79

6.16

mmol/l

2.10

176

1432

Disorders of sclera, cornea, iris and ciliary body

234

1960

1.20

1.95

1.3

6.40

6.34

mmol/l

0.12

212

1806

Acute bronchiolitis

2.15

1.95

1.2

1.3

5.73

6.17

mmol/l

0.27

Otosclerosis

256

0.47

1.94

1.3

1.5

6.37

6.38

mmol/l

0.01

241

Assault

273

1.54

1.94

1.3

1.4

5.91

6.19

mmol/l

0.23

253

Dementia

200

1664

0.83

1.94

1.2

1.4

6.26

6.37

mmol/l

0.20

180

1550

Dermatophytosis

271

2302

1.18

1.91

1.3

6.33

6.26

mmol/l

0.15

253

2128

Chronic sinusitis

180

1474

1.22

1.89

1.5

1.3

6.09

6.40

mmol/l

0.91

167

1362

Retained placenta and membranes, without haemorrhage

225

0.44

1.87

1.2

1.3

5.79

6.28

mmol/l

—

206

Alcohol abuse, main dg, excluding more controls

449

1.41

1.86

1.2

1.4

6.40

6.35

mmol/l

0.05

418

Use of biperiden

144

1.74

1.85

1.1

1.4

4.95

6.67

mmol/l

2.70

132

Spinal stenosis

282

1830

1.17

1.82

1.3

6.68

6.29

mmol/l

1.22

267

1691

Diseases of inner ear

190

2211

0.83

1.82

1.3

6.69

6.35

mmol/l

0.93

178

2046

Granulomatous disorders of skin and subcutaneous tissue

2.18

1.78

2.2

1.2

6.41

6.17

mmol/l

0.10

Postprocedural disorders of digestive system, not elsewhere classified

102

1.88

1.76

1.3

1.4

6.31

6.44

mmol/l

0.07

Acute upper respiratory infections

497

2724

1.12

1.75

1.4

1.3

6.44

6.27

mmol/l

0.57

462

2519

Antepartum haemorrhage, not elsewhere classified

1.90

1.75

1.1

1.3

5.64

6.14

mmol/l

0.38

Erythema multiforme

2.15

1.72

1.4

1.3

6.47

6.46

mmol/l

0.01

Previous suicide attempt

3.88

1.72

1.4

1.1

7.00

6.75

mmol/l

—

Psoriasis

121

962

1.26

1.71

1.4

6.25

6.38

mmol/l

0.24

113

884

Bronchitis, not specified as acute or chronic

250

1.52

1.70

1.4

6.61

6.47

mmol/l

0.13

232

Migraine, single triptan purchase ok & required. ICD-code if available is included

185

1503

0.83

1.68

1.2

1.3

5.75

6.29

mmol/l

2.53

173

1397

Triptan medication for migraine, single purchase ok

185

1503

0.83

1.68

1.2

1.3

5.75

6.29

mmol/l

2.53

173

1397

Soft tissue disorders related to use, overuse and pressure

125

1001

1.25

1.67

1.4

1.3

6.37

6.26

mmol/l

0.19

116

921

Postmenopausal bleeding

485

0.74

1.67

1.2

1.3

6.19

6.60

mmol/l

0.79

456

Fall on and from stairs and steps

112

886

1.27

1.66

1.4

6.14

6.37

mmol/l

0.34

106

815

Malignant neoplasm of vulva, including Hilmo

3.18

1.66

1.2

5.38

7.82

mmol/l

—

Other and unspecified disorders of vitreous body

131

1594

0.81

1.65

1.3

1.4

6.50

6.28

mmol/l

0.36

125

1475

Habit and impulse disorders

2.82

1.65

1.4

1.2

5.63

6.22

mmol/l

—

Polyuria

115

914

1.26

1.65

1.4

6.27

6.29

mmol/l

0.03

101

841

Sleep disorders (combined)

538

2531

1.12

1.65

1.3

6.38

6.24

mmol/l

0.48

496

2343

Infections with a predominantly sexual mode of transmission

100

727

1.28

1.64

1.2

1.3

6.35

6.08

mmol/l

0.39

674

134

1019

1.24

1.64

1.3

6.65

6.31

mmol/l

0.65

128

934

Dental pulpitis, including avohilmo

275

2067

0.86

1.63

1.2

1.3

6.28

6.22

mmol/l

0.12

251

1908

Alzheimer’s disease (Late onset)

104

1107

0.79

1.63

1.3

1.4

6.56

6.42

mmol/l

0.20

1035

Dental caries, including avohilmo

407

1837

1.13

1.63

1.4

1.3

6.18

6.36

mmol/l

0.65

372

1690

Acute alcohol intoxication

123

990

1.24

1.59

1.2

1.4

6.45

6.28

mmol/l

0.24

111

905

Family history of malignant neoplasm

230

1.53

1.59

1.2

1.3

5.93

6.16

mmol/l

0.22

216

Glucagon-like peptide-1 (GLP-1) analogues

113

901

1.26

1.59

1.4

1.3

7.78

5.69

mmol/l

8.90

102

825

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

113

901

1.26

1.59

1.4

1.3

7.78

5.69

mmol/l

8.90

102

825

Dermatitis and eczema

512

2849

1.11

1.58

1.4

1.3

6.17

6.32

mmol/l

0.62

476

2629

Biological medication for rheuma

372

1.40

1.55

1.4

5.74

6.10

mmol/l

0.36

344

Lichen simplex chronicus

107

1.79

1.55

1.5

1.3

5.38

6.71

mmol/l

1.43

100

Schizophrenia

423

1.37

1.55

1.1

1.4

6.15

6.26

mmol/l

0.09

392

Acute and transient psychotic disorders

281

1.46

1.54

1.3

1.4

6.25

6.36

mmol/l

0.10

263

Other specified/unspecified hearing loss

323

1.43

1.53

1.2

1.4

6.26

6.60

mmol/l

0.51

302

Acute alcohol intoxication, ICD10

658

1.29

1.52

1.2

1.4

6.07

6.25

mmol/l

0.24

609

Other disorders of bone

519

1.33

1.52

1.4

5.92

6.31

mmol/l

0.61

482

Myocardial infarction, unclassifiable

149

1098

1.21

1.51

1.3

1.4

7.71

6.30

mmol/l

5.11

135

1000

Fissure and fistula of anal and rectal regions

101

801

1.26

1.50

1.3

6.18

6.37

mmol/l

0.35

734

Hyperfunction of pituitary gland

1.87

1.50

1.2

5.14

6.57

mmol/l

1.60

Disorders of refraction and accommodation

667

1.29

1.48

1.3

6.34

6.27

mmol/l

0.09

613

Inflammatory bowel disease

119

964

1.24

1.47

1.4

6.54

6.26

mmol/l

0.52

114

889

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

259

1.47

1.46

1.4

6.55

6.46

mmol/l

0.08

240

Unspecified mental disorder

144

1191

1.21

1.46

1.2

1.3

6.19

6.29

mmol/l

0.13

127

1097

Anxiety disorders, excluding more controls

333

1909

1.14

1.45

1.3

6.28

6.31

mmol/l

0.07

308

1781

Benign neoplasm: Stomach

344

1.40

1.44

1.4

6.54

6.58

mmol/l

0.04

326

Kela-code for severe mental illness

131

1077

1.22

1.42

1.2

1.4

6.04

6.31

mmol/l

0.44

114

994

Tumor necrosis factor alpha inhibitors

328

1.41

1.42

1.4

5.55

6.12

mmol/l

0.61

304

Complications of labour and delivery

123

837

0.82

1.40

1.2

6.45

6.31

mmol/l

0.25

111

787

Other sleep disorders

380

1.37

1.40

1.3

1.4

5.82

6.32

mmol/l

0.64

354

Deep bite

185

0.52

1.37

1.3

1.4

5.83

6.26

mmol/l

0.36

169

Focal epilepsy, mode (most common among epilepsy diagnosis)

643

1.28

1.36

1.3

1.4

5.88

6.40

mmol/l

1.37

595

Erectile dysfunction

417

1.35

1.36

1.3

1.4

6.55

6.28

mmol/l

0.26

387

Acute appendicitis, with complications

688

1.27

1.35

1.5

1.4

6.74

6.32

mmol/l

0.53

640

Benign neoplasm: Rectosigmoid junction

151

1.60

1.35

1.2

1.5

6.89

6.59

mmol/l

0.19

143

Fracture of skull and facial bones

671

1.27

1.34

1.2

1.4

5.94

6.15

mmol/l

0.35

620

Conjunctivitis (acute, non atopic)

775

1.25

1.34

1.3

6.39

6.32

mmol/l

0.08

710

Diseases of salivary glands

123

1013

1.22

1.33

1.4

1.3

6.25

6.35

mmol/l

0.14

114

932

Gingivitis and periodontal diseases

505

2362

1.10

1.32

1.3

6.13

6.36

mmol/l

1.10

460

2187

Fracture at wrist and hand level

132

1096

1.20

1.30

1.4

1.3

6.51

6.25

mmol/l

0.31

120

996

severe traumatic brain injury, does not include concussion

124

1026

1.21

1.29

1.4

6.62

6.31

mmol/l

0.62

115

934

Varicose veins

301

2012

1.13

1.29

1.4

1.3

6.19

6.35

mmol/l

0.52

281

1860

Oral lichen planus, including avohilmo , including avohilmo

174

0.52

1.29

1.6

1.3

5.58

6.49

mmol/l

—

160

Non-selective monoamine reuptake inhibitors

171

1404

1.18

1.28

1.3

1.4

6.42

6.31

mmol/l

0.17

157

1294

Voice disturbances

109

891

1.23

1.28

1.4

1.3

6.08

6.42

mmol/l

0.59

817

Focal epilepsy

738

1.25

1.28

1.3

1.4

6.11

6.39

mmol/l

0.59

678

Nerve, nerve root and plexus disorders

504

2808

1.10

1.27

1.3

6.59

6.25

mmol/l

1.68

468

2592

Ventral hernia

111

910

1.22

1.27

1.4

1.3

6.31

6.34

mmol/l

0.04

103

824

Dorsopathies

475

2188

1.10

1.26

1.4

1.3

6.37

6.20

mmol/l

0.67

426

2023

Papulosquamous disorders

165

1405

1.18

1.26

1.4

1.3

6.21

6.35

mmol/l

0.32

153

1296

Diseases of pulp and periapical tissues and dental caries

362

1657

1.12

1.26

1.4

1.3

6.20

6.37

mmol/l

0.56

335

1523

Caught, crushed, jammed or pinched in or between objects

118

0.42

1.24

1.0

1.3

6.80

6.40

mmol/l

—

108

Benign neoplasm of brain and other parts of central nervous system

203

0.54

1.24

1.3

1.4

4.70

6.53

mmol/l

1.29

189

Injuries to the shoulder and upper arm

390

2833

1.11

1.23

1.3

6.16

6.32

mmol/l

0.49

367

2611

Alzheimer’s disease (Late onset), excluding more controls

555

0.78

1.21

1.3

1.4

6.57

6.23

mmol/l

0.47

514

Myeloid leukaemia

1.73

1.21

1.6

1.4

6.28

6.39

mmol/l

0.07

Disorders of lacrimal system

180

1546

1.16

1.21

1.3

6.71

6.33

mmol/l

0.95

168

1425

Alcohol abuse, main dg

488

1.29

1.19

1.2

1.4

6.40

6.24

mmol/l

0.16

450

Superficial injury of ankle and foot

264

1.40

1.18

1.3

1.4

7.54

6.29

mmol/l

1.04

244

Polyp of the female genital tract

524

0.79

1.18

1.4

1.3

6.23

6.53

mmol/l

0.47

494

Vitamin deficiency

141

1.57

1.17

1.1

1.4

7.04

6.60

mmol/l

0.37

132

Vitamin deficiency, wide

141

1.57

1.17

1.1

1.4

7.04

6.60

mmol/l

0.37

132

Radiculopathy

632

1.25

1.16

1.2

1.4

6.51

6.30

mmol/l

0.27

589

102

1.67

1.16

1.3

1.2

5.64

6.17

mmol/l

0.54

Alzheimer disease, excluding more controls

634

0.80

1.15

1.2

1.4

6.73

6.20

mmol/l

1.01

586

Nonorganic sleeping disorders, excluding more controls

473

1.29

1.15

1.2

1.3

6.07

6.29

mmol/l

0.29

444

Lower back pain or/and sciatica

480

2865

1.09

1.14

1.4

1.3

6.48

6.27

mmol/l

0.82

442

2651

Crystal arthropathies, rheuma endpoint

1.80

1.11

1.5

5.92

7.40

mmol/l

1.11

Other crystal arthropathies

1.80

1.11

1.5

1.4

5.92

7.22

mmol/l

0.99

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

157

1445

0.86

1.11

1.3

6.21

6.26

mmol/l

0.09

144

1338

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.79

1.11

1.2

1.3

6.45

7.40

mmol/l

0.50

Urticaria

772

1.22

1.10

1.3

6.10

6.34

mmol/l

0.46

709

Fitting and adjustment of other devices

152

1176

1.17

1.10

1.3

6.81

6.26

mmol/l

1.13

140

1069

Symptoms and signs involving speech and voice

142

1212

1.17

1.09

1.4

1.3

6.06

6.36

mmol/l

0.61

131

1108

Exposure to other specified factors

303

2497

1.11

1.09

1.3

6.39

6.26

mmol/l

0.37

283

2298

Maltreatment syndromes

1.73

1.09

1.1

1.2

5.90

6.54

mmol/l

—

Outcome of delivery

152

0.61

1.08

1.0

1.1

5.76

6.17

mmol/l

0.27

136

Traumatic subdural haemorrhage

621

1.24

1.08

1.4

6.77

6.26

mmol/l

0.88

566

Abnormalities of forces of labour

162

0.55

1.08

1.3

1.2

6.06

6.16

mmol/l

—

148

Demyelinating diseases of the central nervous system

177

1.47

1.07

1.1

1.4

5.45

6.32

mmol/l

0.98

162

Hyperplasia of prostate

226

1129

1.14

1.07

1.4

6.26

6.17

mmol/l

0.17

208

1044

Other disorders of lacrimal gland

139

1187

1.17

1.07

1.3

6.72

6.30

mmol/l

0.98

133

1101

Shoulder lesions

364

1996

1.11

1.07

1.3

6.25

6.29

mmol/l

0.10

330

1840

Other disorders of ear

437

2615

1.09

1.06

1.3

6.50

6.29

mmol/l

0.68

408

2410

Additional codes for the location of defect, injury or illness

161

1.50

1.06

1.6

1.4

5.78

6.67

mmol/l

0.79

150

Neurotic, stress-related and somatoform disorders

339

2142

1.11

1.06

1.3

6.27

mmol/l

0.01

309

1981

Other osteochondropathies

170

1.47

1.04

1.5

5.98

6.34

mmol/l

0.26

157

Other diseases of spinal cord

1.68

1.04

1.2

1.3

5.79

6.48

mmol/l

0.49

Gonarthrosis,primary

392

2647

0.91

1.04

1.4

1.3

6.20

6.37

mmol/l

0.61

366

2440

Other symptoms and signs involving the nervous and musculoskeletal systems

168

1460

1.15

1.04

1.3

1.4

6.17

6.33

mmol/l

0.34

158

1340

Early lumbar disc prolapse, operated

154

1.50

1.03

1.2

1.3

5.86

6.01

mmol/l

0.07

144

Coxarthrosis [arthrosis of hip](FG)

279

1759

1.12

1.03

1.4

1.3

6.50

6.37

mmol/l

0.35

265

1614

Single delivery by forceps and vacuum extractor

131

0.60

1.02

1.2

5.80

6.02

mmol/l

0.13

116

Viral warts

563

1.24

1.01

1.4

5.82

6.34

mmol/l

1.02

521

Lesion of sciatic nerve

189

0.58

1.01

1.2

1.4

5.55

6.73

mmol/l

1.57

178

Disorders of eyelid in diseases classified elsewhere

1.66

1.00

1.3

1.4

6.69

6.50

mmol/l

0.08

Reactive arthropathies, FINNGEN

180

1.45

1.00

1.4

6.37

6.35

mmol/l

0.02

163

Depression or dysthymia

316

1573

1.11

1.00

1.4

6.76

6.19

mmol/l

2.29

291

1472

Dementia in other diseases classified elsewhere

201

0.59

1.00

1.0

1.4

5.22

6.69

mmol/l

1.09

190

Melanocytic naevi of upper limb, including shoulder

1.81

0.98

1.5

1.3

6.49

6.64

mmol/l

0.05

Other congenital malformations of circulatory system

1.81

0.98

2.0

1.3

6.80

6.46

mmol/l

0.10

Noise effects on inner ear

157

0.57

0.98

1.2

1.5

6.69

6.39

mmol/l

—

148

Other hearing loss

159

1354

1.15

0.98

1.4

6.48

6.35

mmol/l

0.22

150

1244

Other neurotic disorders

140

1.51

0.97

1.4

1.3

6.73

6.62

mmol/l

0.05

130

Visual disturbances and blindness

225

2006

1.12

0.96

1.3

6.47

6.33

mmol/l

0.37

214

1848

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

247

0.65

0.96

1.4

1.5

6.41

6.45

mmol/l

0.03

231

Anxiety disorders

343

2176

1.10

0.95

1.3

6.27

mmol/l

0.00

313

2013

Agoraphobia

1.90

0.94

1.4

1.0

5.71

7.01

mmol/l

—

Other enthesopathies

113

963

1.17

0.93

1.5

1.3

6.05

6.22

mmol/l

0.33

105

889

Other disorders of pigmentation

142

1.48

0.92

1.2

1.4

6.82

6.56

mmol/l

0.23

131

Single delivery by caesarean section

176

0.68

0.92

1.1

1.2

6.20

5.99

mmol/l

0.26

155

Coxarthrosis, primary, with hip surgery

203

2132

0.89

0.91

1.4

1.3

6.40

6.37

mmol/l

0.06

192

1965

Seborrhoeic keratosis

102

864

1.18

0.91

1.3

1.4

5.98

6.29

mmol/l

0.53

789

Parkinson's disease, strict definition

676

0.80

0.90

1.4

5.63

6.40

mmol/l

1.44

622

Orchitis and epididymitis

384

1.28

0.90

1.4

6.62

6.26

mmol/l

0.33

355

Excessive attrition of teeth

155

1767

0.88

0.90

1.3

6.18

6.25

mmol/l

0.12

145

1630

Atopic dermatitis, strict definition with reimbursement

596

1.22

0.90

1.4

1.3

5.66

6.16

mmol/l

1.13

553

Chondropathies

411

1.27

0.90

1.4

5.69

6.28

mmol/l

0.98

386

Hypothyroidism, other/unspecified

395

2389

1.09

0.89

1.4

1.3

6.35

6.26

mmol/l

0.27

373

2200

Monoamine oxidase A inhibitors

369

1.28

0.86

1.3

1.4

6.22

6.31

mmol/l

0.06

341

Organic, including symptomatic, mental disorders

289

1870

1.10

0.86

1.3

1.4

6.44

6.34

mmol/l

0.24

262

1738

Postprocedural musculoskeletal disorders, not elsewhere classified

247

1.34

0.85

1.1

1.4

6.53

6.55

mmol/l

0.01

232

Missing teeth due to accident, extraction or parodontitis

279

2391

1.10

0.85

1.4

6.28

6.36

mmol/l

0.20

251

2214

Conductive and sensorineural hearing loss

396

2466

1.08

0.84

1.3

6.66

6.31

mmol/l

1.37

373

2272

Use of ropinirole

139

0.57

0.83

1.4

5.64

6.73

mmol/l

—

129

Glaucoma secondary to other eye disorders

138

1.45

0.81

1.5

1.4

6.33

6.55

mmol/l

0.18

132

Infective bursitis

1.58

0.81

1.4

1.5

5.56

6.20

mmol/l

0.58

Parkinson's disease

720

0.82

0.81

1.4

5.68

6.40

mmol/l

1.40

662

Focal epilepsy, strict definition

700

1.19

0.80

1.3

1.4

6.23

6.39

mmol/l

0.26

642

Corneal ulcer

564

1.21

0.79

1.3

1.4

6.76

6.37

mmol/l

0.60

520

Atopic dermatitis

142

1320

0.88

0.79

1.3

6.03

6.23

mmol/l

0.46

135

1216

Hydrocele

583

1.20

0.78

1.3

1.4

5.71

6.25

mmol/l

0.85

542

Other bullous disorders

1.59

0.78

1.7

1.3

5.84

6.64

mmol/l

0.64

Helminthiases

1.63

0.78

1.4

1.3

6.26

6.71

mmol/l

0.40

Visual disturbances

201

1809

1.11

0.78

1.3

1.4

6.38

6.30

mmol/l

0.19

192

1664

Diabetic neuropathy

517

1.22

0.77

1.3

1.4

8.87

7.60

mmol/l

1.92

473

Any dementia

198

1529

0.90

0.77

1.3

1.4

6.27

6.41

mmol/l

0.29

178

1417

Inguinal hernia, bilateral

503

1.22

0.76

1.6

1.4

6.57

6.32

mmol/l

0.20

454

Parkinson's disease, including avohilmo

747

0.83

0.76

1.4

5.74

6.39

mmol/l

1.28

686

Dislocation, sprain and strain of joints and ligaments of knee

168

1732

0.89

0.76

1.2

1.3

6.69

6.21

mmol/l

1.39

158

1596

HSIL lesion of the cervix uteri, vagina or vulva

305

1.28

0.76

1.3

6.12

6.10

mmol/l

0.01

285

Hyperprolactinaemia

1.70

0.76

1.2

5.18

6.46

mmol/l

—

Dissociative [conversion] disorders

1.70

0.76

1.6

1.1

5.57

6.72

mmol/l

—

Postpartum care and examination

120

1.37

0.75

1.2

1.1

5.88

6.06

mmol/l

0.14

106

Salpingitis and oophoritis

395

1.24

0.75

1.3

5.90

6.50

mmol/l

1.03

365

Labour and delivery complicated by umbilical cord complications

1.60

0.75

1.2

1.3

6.09

6.60

mmol/l

0.33

Neovascular glaucoma

141

1.42

0.74

1.5

1.4

6.32

6.38

mmol/l

0.03

133

Schizoaffective disorder

158

1.40

0.74

1.1

1.4

6.54

6.40

mmol/l

0.07

146

Injury of muscle and tendon at shoulder and upper arm level

129

1463

0.88

0.74

1.3

1.4

5.58

6.40

mmol/l

3.69

120

1337

Spondylosis

256

1906

1.10

0.74

1.3

6.35

6.28

mmol/l

0.14

239

1761

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

289

1.28

0.73

1.2

1.5

6.77

6.53

mmol/l

0.20

272

Hypothyreosis and Thyroxine purchase for inclusion criteria

409

2496

1.08

0.73

1.4

1.3

6.38

6.31

mmol/l

0.21

385

2302

Bicipital tendinitis

132

0.60

0.73

1.4

4.67

6.35

mmol/l

—

121

Other/unspecified enthesopathies of lower limb, excluding foot

167

1.38

0.73

1.7

1.4

5.92

6.38

mmol/l

0.47

158

Transport accidents

173

1333

1.12

0.73

1.4

1.3

6.32

6.20

mmol/l

0.24

158

1226

Ulcerative colitis

754

1.17

0.73

1.4

6.58

6.31

mmol/l

0.39

699

Suppurative and unspecified otitis media

758

1.16

0.72

1.3

6.22

6.16

mmol/l

0.08

697

Insomnia

287

2272

0.92

0.72

1.3

6.50

6.28

mmol/l

0.60

268

2100

Iridocyclitis

747

1.17

0.71

1.4

1.3

6.07

6.35

mmol/l

0.47

689

Injury of muscle and tendon at wrist and hand level

433

0.78

0.70

1.3

1.4

6.46

6.25

mmol/l

0.22

399

Anterior Iridocyclitis

656

1.18

0.69

1.4

6.05

6.28

mmol/l

0.33

609

Inguinal or femoral hernia, bilateral

510

1.20

0.68

1.6

1.4

6.57

6.34

mmol/l

0.18

461

Pain in joint

244

1423

1.09

0.68

1.4

1.3

6.29

6.14

mmol/l

0.32

225

1309

Otitis externa

696

1.17

0.66

1.3

1.4

6.57

6.32

mmol/l

0.33

642

Leiomyoma of uterus

194

995

1.11

0.66

1.2

1.3

6.48

6.45

mmol/l

0.07

178

931

Artificial joint operation, meniscal resection

394

2735

0.93

0.66

1.3

6.20

6.35

mmol/l

0.61

371

2523

Polycystic ovarian syndrome, consortium definition

205

1103

1.10

0.66

1.3

1.2

6.36

6.38

mmol/l

0.03

186

1035

Nonorganic sleeping disorders

512

1.19

0.66

1.2

1.4

6.07

6.32

mmol/l

0.34

479

Polymyalgia rheumatica

549

1.19

0.66

1.2

1.4

6.35

6.39

mmol/l

0.03

512

Certain conditions originating in the perinatal period

1.54

0.65

1.4

1.2

5.78

6.10

mmol/l

0.15

Tonsillectomy and adenotomy

115

905

0.88

0.64

1.2

1.3

5.78

6.10

mmol/l

0.71

106

830

Other/unspecified reactive arthropathies

172

1.34

0.63

1.4

6.47

6.59

mmol/l

0.10

160

Neuromuscular dysfunction of bladder

332

1.24

0.63

1.3

1.4

6.28

6.42

mmol/l

0.13

309

Other and unspecified follicular disorders

112

1.43

0.63

1.4

1.3

7.03

6.41

mmol/l

0.46

103

Colonic or urogenital fistula

106

934

1.14

0.63

1.3

6.10

6.33

mmol/l

0.45

101

858

Glaucoma

288

2297

1.08

0.62

1.3

6.52

6.34

mmol/l

0.41

272

2123

Sensorineural hearing loss

380

2413

1.07

0.62

1.3

6.77

6.31

mmol/l

1.92

357

2224

Prolonged pregnancy

158

1.33

0.62

1.4

1.2

4.90

5.99

mmol/l

1.88

142

HSIL lesion of the cervix uteri

253

1.27

0.60

1.2

1.3

6.01

6.15

mmol/l

0.09

233

Presence of other devices

1054

0.88

0.60

1.3

1.4

7.20

6.17

mmol/l

3.07

963

Disorders of vestibular function (Vertigo)

175

1888

0.91

0.59

1.3

6.71

6.36

mmol/l

0.84

163

1740

Bipolar affective disorders

426

1.20

0.59

1.1

1.3

5.82

6.18

mmol/l

0.37

394

Dermatitis herpetiformis

1.52

0.58

1.5

1.2

5.39

6.69

mmol/l

—

Other disorders of eyelid

219

1920

1.09

0.58

1.3

1.4

6.48

6.33

mmol/l

0.39

203

1773

Appendectomy

230

2029

1.08

0.58

1.3

6.03

6.29

mmol/l

0.76

208

1877

Disorders of synovium and tendon

179

1716

0.91

0.58

1.5

1.3

6.42

6.30

mmol/l

0.24

170

1581

Periapical abscess

168

1530

1.10

0.58

1.3

6.20

6.33

mmol/l

0.22

154

1405

Pedal cyclist injured in transport accident

659

0.85

0.57

1.4

5.74

6.30

mmol/l

0.93

608

Extrapyramidal and movement disorders

151

1664

0.91

0.57

1.3

1.4

5.94

6.35

mmol/l

1.17

139

1529

Any dementia, excluding more controls

184

1384

0.91

0.57

1.3

1.4

6.30

6.41

mmol/l

0.20

165

1289

Hypothyroidism, strict autoimmune, 3 medication purchases required

359

2273

1.07

0.57

1.3

6.36

6.31

mmol/l

0.13

341

2100

Other abnormal uterine and vaginal bleeding

485

1.15

0.56

1.3

6.95

6.54

mmol/l

0.69

455

Other congenital malformations of skin

0.58

0.56

2.0

1.2

8.98

6.39

mmol/l

—

Panhypopituitarism

1.46

0.56

1.4

6.33

6.82

mmol/l

—

Diseases of male genital organs

268

1254

1.08

0.56

1.4

6.36

6.10

mmol/l

0.73

247

1161

Presbycusis

730

1.14

0.55

1.4

6.50

6.41

mmol/l

0.10

672

Contact with nonpowered hand tool

122

0.65

0.54

1.5

5.94

6.39

mmol/l

—

114

Early lumbar disc prolapse operation

177

1.30

0.54

1.2

1.3

5.86

6.16

mmol/l

0.16

162

Diabetes mellitus in pregnancy

298

1.18

0.54

1.2

7.07

5.95

mmol/l

1.89

273

Mental retardation, excluding more controls

1.48

0.54

1.6

1.3

5.61

6.82

mmol/l

—

Spermatocele

361

0.80

0.54

1.2

1.4

6.43

6.27

mmol/l

0.13

333

Benign neoplasm: Liver/bile ducts

1.46

0.53

1.6

1.2

6.24

6.31

mmol/l

—

Alzheimer’s disease (Atypical or mixed)

541

0.84

0.53

1.3

1.4

6.54

6.56

mmol/l

0.01

496

Single spontaneous delivery

101

601

0.89

0.52

1.4

1.3

6.54

mmol/l

0.00

555

Other intervertebral disc disorders

375

2127

1.06

0.52

1.4

1.3

6.41

6.23

mmol/l

0.56

348

1966

Benign neoplasm of other and unspecified female genital organs

0.62

0.52

1.0

1.2

5.48

6.57

mmol/l

—

Arthrosis

335

1726

1.07

0.52

1.4

1.3

6.15

6.38

mmol/l

0.74

302

1590

Other demyelinating diseases of the central nervous system

1.41

0.51

1.1

5.00

6.49

mmol/l

—

Other disorders of the musculoskeletal system and connective tissue

499

1.16

0.51

1.1

1.4

6.35

6.36

mmol/l

0.01

467

Acute and subacute iridocyclitis

611

1.15

0.51

1.4

6.16

6.27

mmol/l

0.13

567

Mental retardation

1.40

0.51

1.6

1.2

5.61

6.56

mmol/l

—

Crohn's disease of large intestine

109

1.38

0.51

1.5

1.3

5.93

6.63

mmol/l

0.54

Chronic rhinitis, nasopharyngitis and pharyngitis

111

999

1.11

0.50

1.4

1.3

5.69

6.29

mmol/l

1.95

103

924

Other joint disorders

369

1835

1.06

0.50

1.4

1.3

6.22

6.31

mmol/l

0.23

338

1689

Unspecified urinary incontinence

269

0.78

0.50

1.3

1.4

7.15

6.41

mmol/l

0.51

254

Primary coxarthrosis, bilateral

120

1324

0.91

0.49

1.3

1.4

6.82

6.42

mmol/l

0.84

112

1208

Mood [affective] disorders

385

2636

0.95

0.49

1.3

6.43

6.28

mmol/l

0.46

348

2438

Striking against or struck by other objects

113

1019

1.11

0.49

1.2

1.4

6.17

6.25

mmol/l

0.10

932

Cystitis

344

2168

0.94

0.49

1.4

1.3

6.45

6.28

mmol/l

0.52

314

2013

Other sexually transmitted chlamydial diseases

110

0.64

0.48

1.1

1.2

3.09

5.99

mmol/l

—

103

Coxibs

148

711

1.10

0.48

1.4

6.16

6.46

mmol/l

0.79

138

666

Acetic acid derivatives and related substances

150

711

1.10

0.48

1.4

6.18

6.46

mmol/l

0.42

136

666

Carpal tunnel syndrome

221

2090

0.93

0.48

1.3

6.79

6.32

mmol/l

1.42

207

1925

All dysplastic lesions of the cervix uteri, vagina or vulva

477

1.16

0.47

1.2

6.23

mmol/l

0.01

447

Mood disorders

387

2640

0.95

0.47

1.3

6.43

6.27

mmol/l

0.47

350

2442

Deficiency of other B group vitamins

1.48

0.47

1.1

1.4

7.56

6.80

mmol/l

—

Coxarthrosis

253

1563

1.07

0.47

1.4

1.3

6.47

6.41

mmol/l

0.12

239

1440

Stenosis and insufficiency of lacrimal passages

309

1.20

0.46

1.3

1.4

6.81

6.43

mmol/l

0.27

290

Mouth breathing

156

1434

1.09

0.46

1.3

6.45

6.29

mmol/l

0.25

142

1311

Parkinson's disease, strict definition, excluding more controls

593

0.87

0.46

1.4

5.63

6.24

mmol/l

1.01

544

Blepharochalasis

130

1187

1.10

0.46

1.2

1.3

6.47

6.36

mmol/l

0.19

119

1088

Sequelae of other and unspecified infectious and parasitic diseases

120

1.34

0.46

1.1

1.3

5.62

6.46

mmol/l

0.85

111

Other complications of labour and delivery, not elsewhere classified

108

0.68

0.46

1.1

1.2

5.75

5.68

mmol/l

—

Dementia due to Parkinson's disease

119

0.67

0.46

1.0

1.5

4.35

6.48

mmol/l

—

114

Cramp and spasm

129

1.32

0.45

1.6

1.4

5.86

6.75

mmol/l

0.68

119

Disturbance of activity and attention

114

0.69

0.45

1.0

1.2

6.24

5.84

mmol/l

—

105

Sixth [abducent] nerve palsy

120

0.66

0.45

1.3

1.4

6.88

6.61

mmol/l

—

114

Generalized skin eruption due to drugs and medicaments

103

1.36

0.45

1.6

1.3

6.58

6.70

mmol/l

0.05

Selective serotonin reuptake inhibitors

457

2274

1.05

0.44

1.3

6.45

6.23

mmol/l

0.78

418

2112

Vasomotor rhinitis (mode)

219

0.77

0.43

1.3

1.4

6.82

6.46

mmol/l

0.15

203

Hyperkinetic disorders

124

0.71

0.43

1.0

1.2

5.66

5.91

mmol/l

—

114

therapeutic use

104

1.35

0.43

1.3

7.14

6.88

mmol/l

0.13

Injuries to the neck

668

1.12

0.43

1.5

1.4

6.00

6.30

mmol/l

0.60

619

Adenomyosis (Endometriosis of uterus)

368

1.17

0.42

1.4

1.3

6.02

6.53

mmol/l

0.54

348

Major anomalies of jaw size

1.43

0.42

1.0

1.2

5.64

6.64

mmol/l

—

Short Achilles tendon (acquired)

1.43

0.42

1.9

1.3

5.97

6.67

mmol/l

—

Impingement syndrome of shoulder

880

0.90

0.41

1.3

6.60

6.22

mmol/l

0.48

811

Haemorrhoids and perianal venous thrombosis

120

1305

0.92

0.41

1.3

1.4

6.23

6.37

mmol/l

0.26

110

1204

Sequelae of infectious and parasitic diseases

231

1.21

0.41

1.1

1.3

5.67

6.55

mmol/l

0.89

216

Injury of muscle and tendon at ankle and foot level

1.36

0.41

1.6

1.4

5.64

6.80

mmol/l

—

Anankastic personality disorder

1.36

0.41

1.5

1.2

5.57

6.43

mmol/l

—

Disorders of vitreous body

192

1982

0.93

0.40

1.3

1.4

6.96

6.33

mmol/l

1.81

182

1835

Urolithiasis

134

1452

0.92

0.40

1.5

1.4

6.20

6.28

mmol/l

0.13

124

1335

Carcinoma in situ, bladder

150

1.27

0.40

1.5

7.22

6.54

mmol/l

0.61

141

Delivery

104

603

0.91

0.40

1.4

1.3

6.52

6.54

mmol/l

0.02

556

Diseases of middle ear and mastoid

188

1437

1.07

0.39

1.3

6.31

6.24

mmol/l

0.13

176

1309

Rotator cuff syndrome

282

1915

1.06

0.39

1.3

6.20

6.30

mmol/l

0.24

254

1766

Chalazion

346

0.84

0.39

1.6

1.4

6.10

6.14

mmol/l

0.03

322

Atlantoaxial subluxation

0.00

0.39

0.0

1.3

—

7.10

—

Fall on same level involving ice and snow

226

2128

1.06

0.39

1.3

6.45

6.34

mmol/l

0.23

214

1959

Sleep disorders

308

2342

0.95

0.39

1.3

6.44

6.27

mmol/l

0.46

284

2165

Benign neoplasm: Skin of ear and external auricular canal

148

0.74

0.38

1.3

1.4

6.68

6.53

mmol/l

0.08

143

Benign neoplasm: Long bones of lower limb

1.37

0.38

1.2

5.69

6.52

mmol/l

—

Acute nasopharyngitis (common cold)

259

1.19

0.38

1.4

1.3

6.48

6.39

mmol/l

0.06

231

Sciatica+with lumbago

205

1772

1.06

0.38

1.4

1.3

6.31

6.27

mmol/l

0.08

188

1637

Nasal polyp

779

0.90

0.37

1.3

1.4

6.03

6.39

mmol/l

0.47

719

Pregnancy with abortive outcome

169

945

0.93

0.37

1.3

6.30

6.43

mmol/l

0.28

157

885

Parkinson's disease, excluding more controls

624

0.89

0.37

1.4

5.68

6.17

mmol/l

0.80

573

Campylobacter enteritis

1.39

0.37

1.3

1.4

6.07

6.86

mmol/l

—

Glucosamine medication

211

1787

0.94

0.37

1.4

6.51

6.41

mmol/l

0.21

191

1655

MS-disease / Multiple Sclerosis

143

1.26

0.37

1.2

1.4

5.29

6.39

mmol/l

1.10

129

Crushed, pushed or stepped on by crowd or human stampede

134

1.27

0.36

1.4

1.3

5.91

6.50

mmol/l

0.48

127

Dystonia

146

0.75

0.36

1.4

1.3

6.14

6.62

mmol/l

0.47

135

Disorders of acoustic nerve

0.66

0.36

1.4

1.5

4.04

6.98

mmol/l

—

Spasmodic torticollis

0.65

0.35

1.6

1.2

6.92

6.86

mmol/l

—

Other specified/unspecified inflammatory spondylopathies

1.34

0.35

1.2

1.4

6.57

6.41

mmol/l

0.08

Alzheimer’s disease (Atypical or mixed), excluding more controls

400

0.87

0.35

1.2

1.4

6.57

6.29

mmol/l

0.27

379

Follow-up care involving plastic surgery

0.64

0.35

1.2

4.72

6.70

mmol/l

—

Vascular syndromes of brain in cerebrovascular disorders

208

1.20

0.35

1.3

1.4

6.38

6.69

mmol/l

0.24

196

Wet age-related macular degeneration

863

1.09

0.35

1.4

6.54

6.34

mmol/l

0.26

793

Cyst of Bartholin Gland

1.37

0.34

1.3

1.2

5.53

6.65

mmol/l

—

Artrosis, including avohilmo

371

2120

0.96

0.34

1.3

6.17

6.37

mmol/l

0.66

337

1959

Nontoxic single thyroid nodule

200

0.80

0.34

1.5

6.23

6.55

mmol/l

0.20

191

Gestational diabetes (for exclusion)

366

1.12

0.34

1.2

6.59

5.91

mmol/l

1.16

337

Mental retardation, wide definition

1.36

0.33

1.5

1.2

5.55

6.56

mmol/l

—

Benign neoplasm: Cranial nerves

0.70

0.33

1.3

1.4

4.50

6.74

mmol/l

—

Otitis media, unspecified

193

0.81

0.32

1.2

1.3

6.89

6.34

mmol/l

0.36

178

Menorrhagia

539

0.92

0.32

1.3

6.89

6.49

mmol/l

0.73

509

Seborrhoeic dermatitis

341

1.15

0.32

1.3

1.4

5.90

6.32

mmol/l

0.80

317

Pregnancy, childbirth and the puerperium

469

0.91

0.32

1.3

1.2

6.95

6.57

mmol/l

0.47

433

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

154

0.78

0.32

1.4

1.3

5.88

6.60

mmol/l

0.57

144

Undefined dementia

583

0.90

0.31

1.3

1.4

5.85

6.56

mmol/l

1.31

530

Contact with other sharp object(s)

131

0.76

0.30

1.3

5.29

6.30

mmol/l

—

119

Injury of muscle and tendon at hip and thigh level

283

0.85

0.30

1.6

1.5

6.08

6.30

mmol/l

0.12

259

All dysplastic lesions of the cervix uteri

396

1.13

0.30

1.2

6.15

6.11

mmol/l

0.04

369

Irregular menses

106

776

1.08

0.30

1.4

1.2

5.82

6.22

mmol/l

0.91

728

Contact with heat and hot substances

138

1.23

0.30

1.2

1.3

7.52

6.41

mmol/l

1.45

129

Migraine

116

1009

0.93

0.30

1.3

6.06

6.23

mmol/l

0.43

108

943

Benign neoplasm: Liver

1.27

0.30

1.7

1.3

5.91

6.47

mmol/l

—

Brain meningioma

1.29

0.30

1.2

1.3

7.32

7.01

mmol/l

0.11

Pollen allergy

293

1.15

0.29

1.3

6.44

6.14

mmol/l

0.27

270

Subarachnoid haemorrhage

373

1.13

0.29

1.7

1.4

6.06

6.21

mmol/l

0.19

346

Triptan medication for migraine, min. 3 purchases

119

971

0.93

0.29

1.2

1.3

5.72

6.22

mmol/l

1.50

107

906

Artificial joint re-operation

251

1.16

0.28

1.4

6.82

6.56

mmol/l

0.17

236

Benign neoplasm: Skin of scalp and neck

1.32

0.28

1.3

1.4

5.50

6.88

mmol/l

—

Nonspecific lymphadenitis

129

0.77

0.28

1.8

1.4

5.56

6.42

mmol/l

—

117

Myasthenia gravis

1.25

0.27

1.4

1.3

5.59

6.15

mmol/l

—

Gonarthrosis [arthrosis of knee](FG)

345

1931

1.04

0.27

1.4

1.3

6.26

6.35

mmol/l

0.24

321

1776

Persons encountering health services in circumstances related to reproduction

147

1049

0.94

0.27

1.3

6.05

6.23

mmol/l

0.37

140

954

Foreign body entering into or through eye or natural orifice

224

1.16

0.27

1.7

1.4

6.00

6.45

mmol/l

0.33

205

Other disorders of amniotic fluid and membranes

155

1.20

0.27

1.1

1.3

5.73

5.91

mmol/l

0.21

136

Necrosis of pulp, including avohilmo

175

1836

0.95

0.26

1.3

6.16

6.22

mmol/l

0.11

159

1695

Trochanteric bursitis

437

0.89

0.26

1.3

6.64

6.46

mmol/l

0.17

403

Hypertrophy of breast in women and men

452

1.11

0.26

1.2

1.4

6.72

6.31

mmol/l

0.65

421

Crohn disease (strict definition, all UC cases excluded)

104

1.25

0.26

1.4

1.3

5.79

6.58

mmol/l

0.49

Erythema intertrigo

1.30

0.26

1.3

6.57

6.48

mmol/l

—

Meniscus derangement

231

1626

0.96

0.26

1.3

6.26

6.40

mmol/l

0.37

213

1500

Maternal care for cervical incompetence

0.70

0.26

1.0

1.2

6.62

6.67

mmol/l

—

Acne vulgaris

1.28

0.26

1.2

5.16

5.85

mmol/l

0.97

Ovarian cyst

102

549

1.07

0.25

1.3

6.34

6.46

mmol/l

0.19

518

Benign neoplasm: Pituitary gland, craniopharyngeal duct

138

0.80

0.25

1.2

1.3

6.75

6.54

mmol/l

0.13

128

Preterm labour and delivery

498

0.90

0.25

1.0

1.2

6.41

6.25

mmol/l

0.16

464

Other and unspecified epidermal thickening

1.20

0.25

1.4

6.74

6.99

mmol/l

—

Flat foot [pes planus] (acquired)

266

0.86

0.24

1.3

1.4

7.27

6.43

mmol/l

0.33

247

Infections of genitourinary tract in pregnancy

148

0.81

0.24

1.3

5.64

6.12

mmol/l

0.46

139

Pilonidal cyst

170

1.18

0.24

1.3

4.73

6.08

mmol/l

1.94

155

Peripheral retinal degeneration

1.27

0.24

1.5

1.4

6.51

6.77

mmol/l

0.21

Amblyopia ex anopsia

0.74

0.24

1.3

7.48

6.63

mmol/l

—

Other specified and unspecified retinal disorders

124

1.21

0.24

1.5

1.4

6.37

6.49

mmol/l

0.05

115

Injuries to the wrist and hand

392

2799

0.97

0.23

1.4

1.3

6.22

6.28

mmol/l

0.14

367

2582

Disorders of vitreous body and globe

203

2033

0.96

0.23

1.3

6.91

6.34

mmol/l

1.68

193

1878

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

219

1.14

0.23

1.1

1.2

5.79

5.83

mmol/l

0.02

205

Excessive, frequent and irregular menstruation

561

0.94

0.23

1.3

1.2

6.26

6.43

mmol/l

0.26

530

Open wound of wrist and hand

148

1519

0.95

0.22

1.3

5.98

6.26

mmol/l

0.60

141

1384

Localized swelling, mass and lump of skin and subcutaneous tissue

107

1134

0.94

0.22

1.3

6.22

6.37

mmol/l

0.32

1038

Dermatitis due to substances taken internally

153

1.18

0.22

1.5

1.3

7.01

6.66

mmol/l

0.16

143

Redundant prepuce, phimosis and paraphimosis

779

1.07

0.22

1.5

1.4

6.93

6.12

mmol/l

1.40

718

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.21

0.0

1.5

—

6.56

—

Oesophagitis, drug-induced

0.00

0.21

0.0

1.5

—

6.73

—

Fatigue fracture of vertebra

0.00

0.21

0.0

1.2

—

6.99

—

Accessory breast

0.00

0.21

0.0

1.0

—

6.71

—

Gender identity disorders

0.00

0.21

0.0

1.0

—

6.31

—

Disorders of puberty

0.00

0.21

0.0

1.1

—

6.55

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.2

—

6.43

—

Disorders of puberty, all

0.00

0.21

0.0

1.1

—

6.47

—

Diseases of external ear

132

1257

1.05

0.20

1.3

1.4

6.25

6.34

mmol/l

0.13

120

1150

Cervical disc disorders

135

1416

0.95

0.20

1.3

6.23

6.31

mmol/l

0.11

127

1309

Vaginal lichen planus

0.00

0.20

0.0

1.1

—

6.80

—

Typhoid and paratyphoid fevers

0.00

0.20

0.0

1.5

—

6.91

—

Female infertility

374

0.92

0.20

1.1

1.3

6.05

6.13

mmol/l

0.08

361

Tongue abnormality

187

0.85

0.20

1.5

1.3

5.50

6.60

mmol/l

1.07

175

Traumatic amputation of wrist and hand

155

0.84

0.20

1.4

1.5

7.05

6.38

mmol/l

0.40

144

Other and unspecified nail disorders

1.23

0.20

1.2

7.08

6.41

mmol/l

—

Benign neoplasm: Larynx

113

0.79

0.20

1.2

1.4

6.60

6.40

mmol/l

—

106

Abnormal findings in secretions and smears from cervix uteri vagina vulva

767

0.95

0.19

1.2

6.05

6.29

mmol/l

0.46

719

Carcinoma in situ of other and unspecified sites

165

1.15

0.19

1.5

7.22

6.57

mmol/l

0.59

156

Algoneurodystrophy

1.13

0.18

1.0

1.2

6.33

6.76

mmol/l

—

Atrophic disorders of skin

376

1.09

0.18

1.5

1.3

6.08

6.45

mmol/l

0.51

351

Acute appendicitis

261

2365

1.03

0.18

1.3

6.34

6.24

mmol/l

0.21

239

2180

Gonarthrosis

303

1676

1.03

0.18

1.4

1.3

6.19

6.39

mmol/l

0.58

280

1545

Propionic acid derivatives

136

715

0.96

0.18

1.4

6.42

6.46

mmol/l

0.07

130

670

Laparoscopic right hemicolectomy

223

1.12

0.18

1.1

1.4

7.13

6.60

mmol/l

0.29

211

Inflammatory disease of cervix uteri

153

0.85

0.18

1.6

1.3

6.19

6.59

mmol/l

0.22

145

Acute appendicitis, no complications

174

1797

0.96

0.18

1.3

6.14

6.21

mmol/l

0.13

160

1649

Autonomic disorders

1.15

0.17

1.0

1.3

6.36

6.51

mmol/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

128

675

1.05

0.17

1.5

1.4

6.20

6.50

mmol/l

0.60

118

634

Benign paroxysmal vertigo

105

1101

0.95

0.17

1.3

6.65

6.41

mmol/l

0.34

1012

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

160

1497

1.04

0.17

1.3

6.09

6.31

mmol/l

0.53

145

1393

Postpartum haemorrhage due to anatomy

110

1.18

0.17

1.2

1.3

6.33

6.20

mmol/l

0.10

103

Contact with other hot fluids

0.76

0.17

1.2

7.90

6.23

mmol/l

—

conjunctival degenerations and deposits

0.72

0.17

1.2

1.3

6.40

7.20

mmol/l

—

Depression

352

2444

0.98

0.16

1.3

6.43

6.28

mmol/l

0.43

318

2256

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.18

0.16

1.1

1.3

6.56

mmol/l

—

Allergic purpura

1.18

0.16

1.4

1.2

6.99

6.60

mmol/l

—

Other/unspecified disorders of vestibular function

141

0.85

0.16

1.7

1.4

7.72

6.64

mmol/l

0.67

131

Dysplasia of cervi uteri

358

1.07

0.16

1.2

1.3

6.28

6.23

mmol/l

0.05

342

Contact with sharp glass

1.11

0.16

1.4

1.3

6.15

6.33

mmol/l

—

Other arthrosis

235

1580

1.03

0.16

1.4

1.3

6.00

6.38

mmol/l

1.30

214

1454

Secondary polycythaemia

1.10

0.15

1.1

1.3

7.71

6.36

mmol/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

334

2425

0.98

0.15

1.2

1.3

6.42

6.28

mmol/l

0.39

307

2241

Other diseases of gallbladder

149

1.14

0.15

1.5

1.3

6.43

6.60

mmol/l

0.11

142

Deforming dorsopathies

907

1.05

0.15

1.4

1.3

6.37

6.35

mmol/l

0.03

848

Pain associated with micturition

361

1.08

0.15

1.4

1.3

5.93

6.44

mmol/l

0.81

338

Post-traumatic wound infection, not elsewhere classified

1.13

0.15

1.3

1.4

5.59

6.53

mmol/l

—

Car occupant injured in noncollision transport accident

1.13

0.15

1.3

1.4

6.14

6.49

mmol/l

—

Endometriosis

537

1.05

0.15

1.3

6.25

6.47

mmol/l

0.37

508

Diseases of the ear and mastoid process

490

2507

0.98

0.15

1.3

6.34

6.24

mmol/l

0.32

454

2308

Unspecified dementia

544

0.94

0.14

1.3

1.4

5.85

6.50

mmol/l

1.15

501

Certain zoonotic bacterial diseases

1.08

0.14

1.3

5.63

6.98

mmol/l

—

Meralgia paraesthetica

0.80

0.14

1.4

1.3

4.74

6.77

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.18

0.14

1.5

1.3

5.67

6.45

mmol/l

1.08

Intrahepatic Cholestasis of Pregnancy (ICP)

1.18

0.14

1.5

1.3

5.67

6.22

mmol/l

0.67

Effects of foreign body entering through natural orifice

819

0.95

0.14

1.3

1.4

5.81

6.29

mmol/l

0.95

752

Stomatitis and related lesions

573

0.94

0.14

1.2

1.4

7.01

6.30

mmol/l

0.88

532

Maternal care for known or suspected fetal abnormality and damage

162

1.11

0.14

1.1

1.2

5.80

6.16

mmol/l

0.35

143

Allergic conjunctivitis

166

1567

1.03

0.14

1.3

6.07

6.29

mmol/l

0.56

151

1456

Plantar fascial fibromatosis

266

1.09

0.14

1.2

1.3

5.83

6.28

mmol/l

0.61

249

Calculus of kidney and ureter

127

1316

0.96

0.13

1.5

1.4

6.21

6.30

mmol/l

0.15

119

1208

Acne

122

1.15

0.13

1.1

1.2

5.27

6.01

mmol/l

1.13

113

Excessive earwax

241

2294

1.03

0.13

1.3

1.4

6.49

6.32

mmol/l

0.44

224

2121

Mixed hyperlipidaemia

132

1.14

0.13

1.5

1.4

7.93

6.26

mmol/l

1.18

123

Moderate visual impairment, binocular

110

0.82

0.13

1.2

1.3

7.86

6.89

mmol/l

—

105

Recurrent or chronic depression

116

786

1.04

0.13

1.3

6.40

6.14

mmol/l

0.42

105

733

Trigger finger

423

1.06

0.12

1.6

1.3

7.21

6.29

mmol/l

1.26

393

Other disorders of bladder

531

1.06

0.12

1.5

1.4

5.77

6.34

mmol/l

1.61

486

Benign mammary dysplasia

344

0.93

0.12

1.3

7.14

6.52

mmol/l

0.44

318

Coxarthrosis, primary

283

2443

0.98

0.11

1.4

6.50

6.35

mmol/l

0.42

269

2252

Deviated nasal septum

135

1309

1.03

0.11

1.3

5.80

6.38

mmol/l

1.58

119

1205

Noninflammatory disorders of female genital tract

108

561

0.97

0.11

1.3

1.2

6.41

6.43

mmol/l

0.02

100

530

Lumbar disc prolapse

261

1961

1.02

0.11

1.4

1.3

6.50

6.24

mmol/l

0.75

243

1814

Primary open-angle glaucoma

150

1489

0.97

0.10

1.4

6.43

6.38

mmol/l

0.05

142

1368

Excessive vomiting in pregnancy

115

1.13

0.10

1.3

5.76

6.22

mmol/l

0.32

107

Other diseases of hard tissues of teeth

297

1508

1.02

0.10

1.4

1.3

6.32

6.34

mmol/l

0.05

272

1389

Benign neoplasm of bone and articular cartilage

212

1.09

0.10

1.4

4.82

6.47

mmol/l

1.64

197

Simple and mucopurulent chronic bronchitis

154

1.10

0.10

1.8

1.4

5.23

6.68

mmol/l

1.67

146

Special screening examination for infectious and parasitic diseases

409

0.95

0.10

1.2

5.43

5.94

mmol/l

0.77

375

FESS (DNB20)

359

1.06

0.09

1.4

6.44

6.24

mmol/l

0.17

330

Anti-inflammatory and antirheumatic products, non-steroids

146

715

1.03

0.09

1.4

6.22

6.46

mmol/l

0.49

137

670

Other extrapyramidal and movement disorders in other diseases

879

0.97

0.09

1.3

1.4

5.84

6.39

mmol/l

1.05

808

Pneumoconiosis due to asbestos and other mineral fibres

116

1.12

0.09

1.2

1.5

7.22

6.48

mmol/l

0.35

110

Inflammation of lacrimal passages (acute and unspecified)

1.04

0.09

1.2

1.3

6.00

6.75

mmol/l

—

Disorders of breast

128

1132

1.03

0.09

1.2

1.3

6.46

6.42

mmol/l

0.05

117

1059

Ethmoidectomy

380

1.05

0.08

1.5

1.4

6.38

6.26

mmol/l

0.10

350

Endometriosis ASRM stages 1,2

302

1.06

0.08

1.1

1.3

5.84

6.27

mmol/l

0.48

281

Benign neoplasm: Choroid

214

1.08

0.08

1.2

1.4

6.79

6.59

mmol/l

0.15

202

Burn and corrosion of head and neck

1.03

0.08

1.0

1.2

5.75

6.40

mmol/l

—

LeFortI or BSSO operation

0.82

0.08

1.0

1.2

4.54

6.19

mmol/l

—

Mumps

0.81

0.08

1.6

1.3

5.92

6.25

mmol/l

—

Urethritis and urethral syndrome

0.77

0.08

1.2

6.46

6.93

mmol/l

—

Other sexually transmitted chlamydial diseases

0.77

0.08

1.2

1.1

2.48

6.32

mmol/l

—

Exposure to smoke, fire and flames

1.09

0.08

1.1

1.3

6.71

6.39

mmol/l

—

Diseases of tongue

205

0.93

0.08

1.5

1.4

5.57

6.35

mmol/l

0.83

196

Epiphora

1.03

0.08

1.0

1.3

5.31

6.78

mmol/l

—

Other encephalitis

1.03

0.08

1.1

1.3

6.54

6.92

mmol/l

—

Internal derangement of knee

139

1413

0.98

0.07

1.3

6.37

6.35

mmol/l

0.04

127

1301

Vasomotor and allergic rhinitis

102

1027

0.97

0.07

1.3

6.60

6.31

mmol/l

0.42

945

Intermittent heterotropia

1.12

0.07

1.8

1.3

6.65

6.48

mmol/l

0.08

Muscle strain

1.07

0.07

1.8

1.4

6.16

6.52

mmol/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

169

1097

1.02

0.07

1.3

6.35

6.10

mmol/l

0.56

162

1010

Other disorders of Eustachian tube

1.05

0.07

1.4

1.3

6.50

6.66

mmol/l

—

Encephalitis

1.05

0.07

1.1

1.3

6.16

6.72

mmol/l

—

Appendicitis, broad definition

278

2479

1.01

0.07

1.3

6.33

6.24

mmol/l

0.21

253

2283

Benign neoplasm: Skin of eyelid, including canthus

550

0.96

0.07

1.3

1.4

6.70

6.33

mmol/l

0.46

511

Congenital iodine-deficiency syndrome/hypothyroidism

1.03

0.07

1.5

1.3

6.38

7.04

mmol/l

—

Inflammatory diseases of female pelvic organs

152

1139

0.98

0.07

1.3

6.23

6.39

mmol/l

0.33

140

1066

Other puerperal infections

1.07

0.07

1.1

1.2

4.79

6.25

mmol/l

—

Hypertrophy of breast

326

0.95

0.07

1.1

1.3

6.28

6.26

mmol/l

0.01

302

Female infertility, cervical, vaginal, other or unspecified origin

364

0.96

0.07

1.1

1.3

6.16

6.15

mmol/l

0.00

351

Testicular dysfunction

1.12

0.07

1.2

1.4

8.57

6.27

mmol/l

—

Panniculitis affecting regions of neck and back

1.12

0.07

1.3

1.4

6.05

6.63

mmol/l

—

Other disorders of iris and ciliary body

0.89

0.06

1.9

1.4

7.60

6.67

mmol/l

—

Use of rasagiline

0.86

0.06

1.3

1.4

5.41

6.57

mmol/l

—

Embedded teeth, including avohilmo

128

1.09

0.06

1.2

5.55

6.20

mmol/l

0.47

120

Primary open-angle glaucoma, strict

124

1212

1.02

0.06

1.4

6.48

6.43

mmol/l

0.05

119

1105

Premature rupture of membranes

204

0.95

0.06

1.1

1.3

5.75

6.10

mmol/l

0.39

182

Hyperkinetic disorders, excluding more controls

100

0.86

0.06

1.0

1.2

5.66

5.92

mmol/l

—

Medical abortion

175

934

1.02

0.06

1.4

1.3

6.26

6.44

mmol/l

0.45

164

875

Monoarthritis, not elsewhere classified

119

1.09

0.06

1.4

6.02

6.82

mmol/l

0.46

111

Other noninflammatory disorders of cervix uteri

121

0.91

0.06

1.2

1.3

6.73

6.65

mmol/l

0.03

114

Allergic rhinitis

654

1.03

0.06

1.3

1.4

6.59

6.14

mmol/l

0.61

606

Spontaneous abortion

100

688

0.98

0.05

1.2

6.60

6.32

mmol/l

0.50

645

Diseases of appendix

280

2496

1.01

0.05

1.3

6.33

6.24

mmol/l

0.21

254

2299

Benign neoplasm: Other and unspecified parts of mouth

100

1.10

0.05

1.5

1.3

8.15

6.66

mmol/l

1.23

Mood disorders, excluding more controls

377

2230

1.01

0.05

1.3

6.45

6.30

mmol/l

0.43

342

2084

Other benign neoplasms of skin

151

1489

1.01

0.04

1.3

6.19

6.39

mmol/l

0.50

142

1366

Speech disturbances, not elsewhere classified

353

0.96

0.04

1.5

1.4

6.08

6.53

mmol/l

0.41

330

Other intracranial haemorrhages

140

0.93

0.04

1.4

7.08

6.26

mmol/l

0.55

131

Macular hole

221

0.95

0.04

1.3

1.4

6.00

6.51

mmol/l

0.36

207

Carcinoma in situ of skin of trunk

150

1.07

0.04

1.3

1.5

5.49

6.55

mmol/l

0.72

143

Other and/or unspecified nontoxic goitre

231

0.95

0.04

1.5

1.4

6.52

6.62

mmol/l

0.05

220

Cervicalgia

705

0.98

0.04

1.3

6.74

6.34

mmol/l

0.45

660

Conjunctivitis

252

2087

1.01

0.03

1.3

6.09

6.33

mmol/l

0.77

230

1927

Benign leiomyoma with endometriosis

381

0.97

0.03

1.4

1.3

6.78

6.62

mmol/l

0.13

355

Disorders of conjunctiva

294

2374

0.99

0.03

1.3

6.15

6.32

mmol/l

0.53

269

2192

Other diseases of upper respiratory tract

504

2614

1.00

0.03

1.4

1.3

6.20

6.34

mmol/l

0.51

464

2418

Glaucoma-related operations

229

0.96

0.03

1.4

6.21

6.74

mmol/l

0.38

216

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

132

1.06

0.02

1.5

1.3

5.78

6.37

mmol/l

0.66

121

Glaucoma, exfoliation

470

1.02

0.02

1.4

5.82

6.57

mmol/l

1.29

434

Examination and encounter for administrative purposes

168

0.95

0.02

1.8

1.3

6.68

6.20

mmol/l

0.37

157

Carcinoma in situ of breast, intraductal

198

0.96

0.02

1.2

1.3

6.52

6.55

mmol/l

0.02

184

Hereditary corneal dystrophies

103

1.07

0.02

1.2

1.4

6.85

6.58

mmol/l

0.16

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

107

0.93

0.02

1.5

1.2

5.68

6.18

mmol/l

—

Other degenerative diseases of the nervous system

127

942

1.01

0.01

1.2

1.4

6.24

6.15

mmol/l

0.14

111

868

Oxicams

123

694

1.01

0.01

1.3

1.4

5.80

6.50

mmol/l

2.09

111

651

Glaucoma suspect

151

1516

1.00

0.00

1.3

1.4

6.68

6.35

mmol/l

0.70

143

1391

Other diseases of lip and oral mucosa

135

1356

1.00

0.00

1.3

6.47

6.36

mmol/l

0.18

125

1251

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

860

1.01

0.00

1.4

1.3

6.24

6.20

mmol/l

0.04

797

Personal history of malignant neoplasm

155

0.97

0.00

1.5

1.4

6.07

6.23

mmol/l

0.06

148

Contact with machinery

402

0.99

0.00

1.5

1.4

5.78

6.33

mmol/l

0.69

364

Endovascular or surgical operations to intracerebral aneurysms

185

0.97

0.00

1.4

5.53

6.60

mmol/l

1.65

170

Postprocedural disorders of nervous system

129

1.01

0.00

1.2

1.3

6.00

6.36

mmol/l

0.22

117

Pediculosis, acariasis and other infestations

141

0.99

0.00

1.2

1.3

6.59

6.32

mmol/l

0.17

128

Mixed conductive and sensorineural hearing loss

475

0.99

0.00

1.3

1.4

6.35

6.41

mmol/l

0.06

440

Inflammatory diseases of prostate (prostatitis)

605

1.01

0.00

1.6

1.4

6.54

6.22

mmol/l

0.58

558

Other headache syndromes

131

1304

1.00

0.00

1.3

6.49

6.23

mmol/l

0.52

121

1211

Other disorders of conjunctiva

534

0.99

0.00

1.3

1.4

6.50

6.37

mmol/l

0.15

493

Struck by thrown, projected or falling objec

132

0.98

0.00

1.9

1.4

6.51

6.60

mmol/l

0.05

120

Allergic contact dermatitis

333

0.99

0.00

1.2

1.4

6.38

mmol/l

0.00

316

Other specific joint derangements/joint disorders

270

1745

1.00

0.00

1.4

1.3

6.34

6.31

mmol/l

0.05

250

1607

Dislocation, sprain and strain of joint and ligaments of hip

109

1.01

0.00

1.6

1.4

6.42

6.59

mmol/l

0.17

103

Scabies

1.03

0.00

1.1

1.2

6.74

6.37

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

136

1.03

0.00

1.5

1.3

5.78

6.48

mmol/l

0.85

128

Abnormal findings on diagnostic imaging of central nervous system

102

0.98

0.00

1.3

6.37

6.64

mmol/l

—

Other disorders of nervous system

217

1.01

0.00

1.9

1.5

6.49

6.47

mmol/l

0.01

202

Other congenital malformations

161

0.99

0.00

1.6

1.3

6.69

6.36

mmol/l

0.13

147

Other vitreous opacities

125

1.04

0.00

1.2

1.4

5.30

6.58

mmol/l

1.09

117

Endometriosis of pelvic peritoneum

310

0.98

0.00

1.1

1.3

5.84

6.27

mmol/l

0.48

298

Myotonic dystrophy (Steinert)

0.00

0.0

1.2

—

6.12

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

0.0

1.1

—

6.14

—

Sleepwalking [somnambulism]

0.00

0.0

1.0

—

7.78

—

Other sudden death, cause unknown

0.00

0.0

1.6

—

5.94

—

Enterobiasis

0.00

0.0

1.2

—

7.10

—

Flexion deformity

0.00

0.0

1.0

—

6.90

—

Actinic reticuloid

0.00

0.0

1.2

—

6.76

—

Other and unspecified cicatricial alopecia

0.00

0.0

1.0

—

7.71

—

Mechanical strabismus

0.00

-0.00

0.0

1.0

—

6.46

—

Hypospadias

0.00

-0.00

0.0

1.2

—

7.04

—

Precocious central puberty

0.00

-0.00

0.0

1.3

—

5.70

—

Reduction defects of lower limb

0.00

-0.00

0.0

1.2

—

6.93

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.97

-0.00

1.2

1.3

6.93

6.79

mmol/l

—

Contact with hypodermic needle

0.00

-0.00

0.0

1.1

—

5.34

—

Onychogryphosis

0.00

-0.00

0.0

1.0

—

6.70

—

Relapsing fevers

0.00

-0.00

0.0

1.1

—

7.16

—

Hypotony of eye

0.00

-0.00

0.0

1.2

—

6.30

—

Other hypertrichosis

0.00

-0.00

0.0

1.0

—

6.30

—

0.00

-0.00

0.0

1.1

—

7.61

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.0

—

7.63

—

Optic neuritis

1.00

-0.00

1.1

1.2

7.35

6.48

mmol/l

—

Relapsing fevers

0.00

-0.00

0.0

1.1

—

7.16

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.5

—

6.20

—

Testicular hypofunction

0.92

-0.00

1.3

1.5

8.23

6.33

mmol/l

—

Benign neoplasm: Respiratory system, unspecified

0.00

-0.00

0.0

1.7

—

6.33

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.1

—

6.87

—

Polyp of middle ear

0.00

-0.00

0.0

1.2

—

6.56

—

Fractures involving multiple body regions

0.00

-0.00

0.0

1.4

—

6.53

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.2

—

7.06

—

Carcinoma in situ of oral cavity and pharynx

0.00

-0.00

0.0

1.1

—

6.91

—

Melanocytic naevi of scalp and neck

0.85

-0.00

1.6

1.3

6.54

6.49

mmol/l

—

Microtia (small ears)

0.00

-0.00

0.0

1.2

—

8.00

—

Toxic encephalopathy

0.00

-0.00

0.0

1.0

—

6.82

—

Cyst of spleen

0.00

-0.00

0.0

1.0

—

6.68

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.2

—

6.12

—

Dislocation of lens

1.02

-0.00

1.7

1.3

9.15

6.77

mmol/l

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.2

—

7.06

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.2

—

6.20

—

Use of bromocriptine

0.00

-0.00

0.0

1.2

—

6.67

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.4

—

7.24

—

Lactose intolerance

0.85

-0.00

2.4

1.3

6.30

6.77

mmol/l

—

Disorders of puberty, other/unspecified

0.00

-0.00

0.0

1.2

—

7.12

—

Congenital varicose veins

0.00

-0.00

0.0

1.0

—

7.90

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.2

—

7.34

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.0

—

7.63

—

Down's syndrome

0.00

-0.00

0.0

1.0

—

7.36

—

Dislocation, sprain and strain of joints and ligaments of head

0.92

-0.00

1.7

1.2

7.33

6.72

mmol/l

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

1.3

—

6.28

—

Spina bifida

0.00

-0.00

0.0

1.0

—

7.28

—

Family history of certain disabilities and chronic diseases leading to disablement

1.01

-0.00

1.3

1.2

5.43

6.53

mmol/l

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.0

—

7.44

—

Retinoschisis and retinal cysts

1.01

-0.00

1.2

1.6

6.92

6.87

mmol/l

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.0

—

7.63

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

-0.00

0.0

1.5

—

6.50

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

1.2

—

6.03

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

6.20

—

Acanthosis nigricans

0.00

-0.00

0.0

1.3

—

6.13

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.2

—

6.62

—

Benign neoplasm: Pancreas

0.91

-0.00

1.6

1.4

5.89

6.55

mmol/l

—

Use of peginterferon beta-1a

0.00

-0.00

0.0

1.0

—

6.00

—

Other infestations

0.94

-0.00

1.4

1.2

7.30

6.26

mmol/l

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.2

—

7.72

—

0.00

-0.00

0.0

1.2

—

6.68

—

Allergic contact dermatitis due to drugs in contact with skin

1.00

-0.00

1.7

1.2

5.87

6.71

mmol/l

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.0

—

7.33

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.0

—

7.02

—

Knuckle pads

0.00

-0.00

0.0

1.5

—

6.58

—

Chloasma

0.00

-0.00

0.0

1.0

—

6.53

—

Benign neoplasm: Skin of lower limb, including hip

1.00

-0.00

1.9

1.3

5.26

6.84

mmol/l

—

Other facial nerve disorders

0.98

-0.00

1.0

1.3

6.40

6.94

mmol/l

—

Degenerative and vascular disorders of ear

0.00

-0.00

0.0

1.2

—

6.22

—

Palatinal maxillary operation

0.00

-0.00

0.0

1.0

—

6.40

—

Other chromosome abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.0

—

7.66

—

Lichen planopilaris

0.00

-0.00

0.0

1.3

—

6.13

—

Discharge of firework

0.00

-0.00

0.0

1.2

—

6.86

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

6.16

—

Changes in corneal membranes

0.00

-0.00

0.0

1.1

—

6.43

—

Lagophthalmos

1.02

-0.00

1.2

1.3

4.74

6.78

mmol/l

—

Maxillary prognathism

0.00

-0.00

0.0

1.1

—

6.19

—

Injury of muscle and tendon at neck level

0.00

-0.00

0.0

1.2

—

6.74

—

Impacted maxillary molar

1.00

-0.00

1.8

1.1

5.50

6.00

mmol/l

—

Other cestode infections

0.00

-0.00

0.0

1.1

—

6.69

—

Complications of the puerperium, not elsewhere classified

0.93

-0.00

1.4

5.56

6.42

mmol/l

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.1

—

6.16

—

Food allergy

0.00

-0.00

0.0

1.0

—

7.03

—

Postpolio syndrome

0.00

-0.00

0.0

1.2

—

6.93

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.0

—

6.40

—

Hypertrophy of bone

0.00

-0.00

0.0

1.0

—

7.76

—

Calcium deposit in bursa

0.00

-0.00

0.0

1.3

—

5.68

—

Other protozoal intestinal diseases

1.02

-0.00

1.2

6.72

6.49

mmol/l

—

Yaws

0.00

-0.00

0.0

1.2

—

6.06

—

Other and unspecified mononeuropathies of lower limb

0.87

-0.00

1.3

5.98

7.12

mmol/l

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.2

—

6.28

—

Other porphyria

0.00

-0.00

0.0

1.4

—

6.80

—

Other helminthiases

0.00

-0.00

0.0

1.2

—

6.29

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.2

—

7.47

—

Disorders of phosphorus metabolism and phosphatases

0.00

-0.00

0.0

1.7

—

6.51

—

Drug-induced cataract

0.88

-0.00

1.2

8.68

6.29

mmol/l

—

Burn and corrosion of trunk

1.01

-0.00

1.1

1.3

6.00

6.67

mmol/l

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.2

—

7.70

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS